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ABSTRACT OF DISSERTATION 
 
NONINVASIVE ASSESSMENT AND MODELING OF DIABETIC 
CARDIOVASCULAR AUTONOMIC NEUROPATHY 
              Noninvasive assessment of diabetic cardiovascular autonomic 
neuropathy (AN): Cardiac and vascular dysfunctions resulting from AN are 
complications of diabetes, often undiagnosed. Our objectives were to: 1) 
determine sympathetic and parasympathetic components of compromised blood 
pressure regulation in patients with polyneuropathy, and 2) rank noninvasive 
indexes for their sensitivity in diagnosing AN.  Continuous 12-lead 
electrocardiography (ECG), blood pressure (BP), respiration, regional blood flow 
and bio-impedance were recorded from 12 able-bodied subjects (AB), 7 diabetics 
without (D0), 7 with possible (D1) and 8 with definite polyneuropathy (D2), during 
10 minutes supine control, 30 minutes 70-degree head-up tilt and 5 minutes 
supine recovery. During the first 3 minutes of tilt, systolic BP decreased in D2 
while increased in AB. Parasympathetic control of heart rate, baroreflex 
sensitivity, and baroreflex effectiveness and sympathetic control of heart rate and 
vasomotion were reduced in D2, compared with AB. Baroreflex effectiveness 
index was identified as the most sensitive index to discriminate diabetic AN. 
               Four-dimensional multiscale modeling of ECG indexes of diabetic 
autonomic neuropathy: QT interval prolongation which predicts long-term 
mortality in diabetics with AN, is well known. The mechanism of QT interval 
prolongation is still unknown, but correlation of regional sympathetic denervation 
of the heart (revealed by cardiac imaging) with QT interval in 12-lead ECG has 
been proposed. The goal of this study is to 1) reproduce QT interval prolongation 
seen in diabetics, and 2) develop a computer model to link QT interval 
prolongation to regional cardiac sympathetic denervation at the cellular level. 
From the 12-lead ECG acquired in the study above, heart rate-corrected QT 
interval (QTc) was computed and a reduced ionic whole heart mathematical 
model was constructed. Twelve-lead ECG was produced as a forward solution 
from an equivalent cardiac source. Different patterns of regional denervation in 
cardiac images of diabetic patients guided the simulation of pathological changes. 
Minimum QTc interval of lateral leads tended to be longer in D2 than in AB. 
 
 
Prolonging action potential duration in the basal septal region in the model 
produced ECG and QT interval similar to that of D2 subjects, suggesting 
sympathetic denervation in this region in patients with definite neuropathy. 
 
KEYWORDS: blood pressure regulation, spectral power, baroreflex, twelve-lead 
ECG, forward solution 
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Part 1. Noninvasive assessment of diabetic 
cardiovascular autonomic neuropathy 
1.1 Chapter One:  Introduction 
Neuropathy is one of the complications of diabetes. Diabetic neuropathy 
affects sensory, motor and autonomic nerves. Cardiovascular autonomic 
neuropathy (CAN) is a common and serious type of neuropathy, that involves the 
damage of both sympathetic and parasympathetic branches of autonomic nerves 
innervating the heart and blood vessels, causing abnormal regulation of  heart 
rate and vascular dynamics (128).  
The pathogenesis of neuropathy in diabetic patients is still not clear. 
Current hypotheses concerning the multiple etiologies of diabetic neuropathy 
include metabolic insult to nerve fibers, neurovascular insufficiency, autoimmune 
damage and neurohormonal growth factor deficiency, resulting in nerve 
degeneration or gene-related neural damage (128, 130). The prevalence of CAN 
has been determined to be 25.3% for individuals with Type 1 diabetes and 34.3% 
for individuals with Type 2 diabetes, as diagnosed by clinical cardiovascular 
reflex tests currently in use (see below) (143).  
Cardiovascular autonomic neuropathy is associated with increased risk of 
occurrence of cardiac events including myocardial infarction, heart failure, 
ventricular tachycardia or fibrillation (128). The 5-year mortality of diabetics with 
CAN is three times higher than in diabetics without CAN  (128). The quality of life 
was decreased in diabetic patients with severe CAN due to orthostatic 
hypotension, amputation, or other symptoms. Treatment of cardiovascular 
manifestations of diabetic autonomic neuropathy includes intensive glycemic 
control to prevent the onset of diabetic autonomic neuropathy and slow the 
progression (129) . In addition, a variety of treatments are available to alleviate 
the symptoms of autonomic neuropathy (130). The onset of CAN occurs early in 
diabetes, and patients are usually asymptomatic for years and are not able to 
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sense when they are becoming hypoglycemic or having a heart attack (130). 
Early diagnosis and treatment is the key to effectively treating CAN. 
Current clinical tests of CAN rely on a battery of cardiovascular reflex tests 
called Ewing tests (39). Although useful, these tests require voluntary 
participation and the sensitivity of these tests is limited. For example, the direct 
measure of cardiac sympathetic innervation determined from 
metaiodobenzylguanidine (MIBG) scintigraphy revealed that abnormal cardiac 
sympathetic innervation occurred earlier than previously known from Ewing, and 
other, tests and, in fact, was evident in diabetic patients whose Ewing tests were 
still normal (49). However, MIBG scintigraphy is expensive, invasive and time 
consuming, and is thus not suitable for routine screening of CAN. In the last two 
decades, alterations in power spectral analysis of heart rate variability have been 
related to abnormal Ewing tests in diabetic patients, reflecting mostly 
parasympathetic dysfunction (32, 45, 60, 144).  
1.1.1 Objective 
The present study aimed to assess the function of both sympathetic and 
parasympathetic braches of the autonomic nervous system in diabetic patients, 
in order to develop indexes suitable for screening of diabetic autonomic 
neuropathy. Passive head-up tilt was used to stimulate autonomic regulation of 
cardiovascular responses to orthostatic stress. Cardiovascular variables were 
acquired from able-bodied subjects, diabetic patients without neuropathy, 
diabetic patients with mild neuropathy and diabetic patients with severe 
neuropathy. The specific goals of this study were to 1) assess dysfunction of 
autonomic regulation of cardiovascular system in diabetic patients, 2) develop 
indexes of diabetic cardiovascular autonomic neuropathy that are noninvasive, 
sensitive, cost-effective and easy to acquired and 3) further explore mechanisms 
of autonomic regulation of the cardiovascular system of normal humans by 
comparing with autonomic failure in diabetics. 
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In this study, 12-lead ECG was also acquired to assess cardiac function in 
supine diabetic patients. Because of the lack of cardiac imaging data of 
sympathetic innervation, a heart-torso computer model was developed to assess 
dysfunction of sympathetic innervation of the heart in diabetic patients. Because 
of the extended length of the content, 12-lead ECG and modeling are included in 
Part 2 of this document. Part 1 focuses on blood pressure regulation in diabetic 
and nondiabetic subjects in response to head-up tilt. 
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1.2 Chapter Two: Background 
1.2.1 Physiological Response to Orthostatic Stress 
Demands for autonomic regulation of blood pressure at supine position 
are minimum, therefore passive head-up tilt (47) was used to activate autonomic 
regulation by challenging the cardiovascular system during exposure to gravity 
while minimizing activation of postural muscles, primarily the legs. The 
hydrostatic pressure gradient along the length of the body, due to the drag of 
gravity, increases transmural pressure of the vessels below the heart, thus 
increasing venous volume by approximately 500 mL (79). In healthy subjects, 
reflexes elicited by the unloading of arterial baroreceptors and cardiopulmonary 
mechanoreceptors restore blood pressure rapidly. The reflexes act by increasing 
heart rate, contractility and vascular resistance. After the initial response, 
hormonal regulation predominates in blood pressure regulation by further 
vasoconstriction and maintaining plasma volume. These responses are 
described in detail below.  
Arterial baroreceptors and cardiopulmonary receptor are sensory stretch 
receptors, which sense arterial and cardiac filling pressures. This information is 
transmitted to the brainstem where it is integrated with information from other 
sensors. Sympathetic and parasympathetic outflows from the brainstem are 
adjusted to initiate the desired cardiovascular response. These reflexes function 
via negative feedback (79). 
The cardiac pre-ganglionic parasympathetic fibers synapse the post-
ganglionic parasympathetic fibers near the heart. Parasympathetic fibers 
innervate the sinoatrial (SA) and atrioventricular (AV) nodes. Post-ganglionic 
parasympathetic fibers release the neurotransmitter acetylcholine (ACh) from the 
nerve terminal, which acts by binding to muscarinic M2-receptors on the myocyte 
membrane (79). ACh slows the pacemaker potential decay and hyperpolarizes 
the membrane, resulting in slowing of heart rate. ACh reduces the pacemaker 
slope via an inhibitory G protein-adenylate cyclase-cAMP-PKA pathway. On the 
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other hand, the hyperpolarizing effect of ACh is mediated through a G-protein-
KACh channel pathway, which is a rapid pathway. ACh is quickly removed from 
the junctional region by the enzyme cholinesterase. These mechanisms account 
for the rapidity of the response, with which vagal stimulation slows the heart and 
the reduction of vagal activity speeds the heart, within one heart beat (79). 
The efferent cardiac pre-ganglionic sympathetic fibers arise from the 
thoracic spinal cord, segments T1 – T5, and synapse in the sympathetic chain. 
The post-ganglionic fibers innerve the SA node, the AV node, and the 
myocardium of atria and ventricles. Post-ganglionic sympathetic fibers release 
the neurotransmitter norepinephrine (NE), which binds to adrenergic
 
receptors in 
the heart. There are α-, β
1 
and β
2 
–receptors in the heart, while β
1 
receptors 
predominate. Activation of the β
1 
receptors induces the following effects over 
several beats: increased heart rate, increased AV node conduction velocity, 
shortened myocyte action potential, increased contractile force and increased 
rate of relaxation. These responses are induced by β
1 
receptors activating the 
cAMP-PKA pathway, which leads to changes in ion channel and pump activity. 
The termination of the action of NE is partly by diffusion into the bloodstream, 
which washes it away; and partly by reuptake into the sympathetic nerves. The 
slow activation and termination processes explain the slow response to, and 
recovery from, sympathetic stimulation. Epinephrine, which is secreted into the 
bloodstream by the medulla of the adrenal gland in response to preganglionic 
sympathetic fiber activity, acts in a similar way as NE at the heart  (79). 
In addition to the control of the heart, sympathetic neural activity controls 
vascular resistance by controlling the contraction and relaxation of vascular 
smooth muscle (VSM) cells. The post-ganglionic sympathetic neurotransmitter, 
NE, binds to α-adrenoreceptors on the membrane of VSM cells. Activation of α-
adrenoreceptors induces VSM contraction by increasing cytosolic free [Ca2+], 
due to 1) sustained membrane depolarization through PLC-IP3-DAG pathway in 
many arteries, 2) firing of action potentials in response to strong sympathetic 
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stimulation in arterioles, small arteries and veins, and 3) mechanisms 
independent of membrane depolarization in large arteries. Activation of 
sympathetic fiber is tonic, and reduced sympathetic activity results in vasodilation 
(79). 
Within the first few minutes of head-up tilt, healthy persons usually have 
an initial drop in blood pressure, sensed by arterial baroreceptors and 
cardiopulmonary receptors, which rapidly bring back blood pressure by 
withdrawal of parasympathetic outflow and an increase in sympathetic outflow. 
Withdrawal of parasympathetic outflow to the heart causes an increase of heart 
rate. Increased sympathetic outflow to the heart results in increases of heart rate 
and heart contractility. In addition, increased sympathetic outflow to peripheral 
vasculature causes constriction of resistance vessels and thus an increase in 
total peripheral resistance. At the capillary level, constriction of arterioles causes 
decreased hydrostatic pressure thereby increasing osmotic absorption of 
interstitial fluid in to the plasma compartment which helps to increase blood 
return. Finally, increased sympathetic outflow results in venoconstriction, which 
can displace blood from the big reservoirs in the intestinal tract, liver and skin (79, 
109).  
During longer head-up tilt, regulation by hormones predominates. The 
effective hormones at different times are epinephrine, norepinephrine, renin, 
angiotensin II, aldosterone, vasopressin, etc, to vasoconstrict and maintain 
plasma volume (109).    
It should be noted that skin is an important organ in both regulation of 
blood pressure and thermoregulation. In human, approximately 95% of the skin is 
hairy skin and the other 5% is non-hairy skin which is primarily at palmar surface 
of the hands, soles of the feet and part of the face (59). Circulations in both types 
of skin are controlled by the sympathetic nervous system: hairy skin is controlled 
by both cholinergic (active vasodilation) and adrenergic (vasoconstriction) 
branches of the sympathetic nerves and non-hairy skin is controlled by 
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adrenergic (vasoconstriction) sympathetic nerves (21). Arteriovenous 
anastomoses (AVA) are present in the non-hairy skin and are innervated by 
adrenergic sympathetic nerves which are tonically active, while in hairy skin, AVA 
rarely exist (21). It was reported that there is a reflex vasoconstriction in hairy 
skin in response to head-up tilt, while the non-hairy skin is not involved in this 
response (109). 
1.2.2 Detection of Diabetic CAN 
The damage of nerve fibers in autonomic neuropathy is believed to be 
length dependent. It occurs earliest in parasympathetic fibers which are longer 
fibers, followed by damage in shorter sympathetic fibers (128, 130). Ewing tests 
were developed several decades ago and serve as a noninvasive measure of 
cardiovascular autonomic neuropathy in both branches (39). Ewing tests consist 
of 5 reflex tests, including heart rate response to Valsalva maneuver, heart rate 
variation during deep breathing, immediate heart rate response to standing, 
(controlled predominantly by parasympathetic nerves), blood pressure response 
to standing and blood pressure response to sustained handgrip, (controlled 
predominantly by sympathetic nerves) (39). If the results of two or more of these 
tests are abnormal, the patient is diagnosed to have CAN. Although it is useful in 
detection of cardiovascular autonomic neuropathy, this battery of tests requires 
voluntary participation of patients and involves specialized operations from heath 
care providers. In addition, its manifestations lag behind abnormalities in 
spontaneous baroreflex function (44) and cardiac imaging of sympathetic 
innervation to the myocardium (49). 
A direct measure of cardiac sympathetic innervation to the myocardium 
can be performed by using a radio-labeled norepinephrine analog and 
tomography of uptake of this analog into nerve terminals. The most commonly 
used neuronal tracers are MIBG, used with single photon emission computed 
tomography (SPECT), and 11C-meta-hydroxyephedrine (HED), used with 
positron emission tomography (PET)  (63). In normal human subjects, cross 
sections of MIBG-SPECT or HED-PET images demonstrated homogeneous 
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uptake of tracer and a complete ventricular structure, while in diabetic patients, 
reduced tracer uptake in the whole left ventricle or regions of the left ventricle 
have been observed, even in those without signs of neuropathy (22, 49, 56, 75, 
91, 93, 112-115, 123). These techniques provide insight to sympathetic 
innervation of the heart, although they are not suitable for routine screening. 
Other techniques are being examined for their potential to provide in-depth, 
easy to administer, diagnostic tools. Comparisons of heart rate variability, low (LF) 
and high (HF) frequency components of heart rate oscillations, have been 
correlated with abnormal results of Ewing tests (32, 45, 60, 144). Diabetic 
patients with abnormal Ewing results also demonstrated reduced LF spectral 
power of systolic blood pressure compared to able bodied controls or compared 
to diabetics with normal results in Ewing tests, during one hour supine or a short 
period of standing (32, 144). In diabetics with no signs of autonomic neuropathy, 
the numbers of spontaneous baroreflex sequences were reduced and slopes of 
baroreflex sequences were smaller compared to controls (32, 44). Heart rate 
variability and baroreflex sequences, acquired during a short period of time, 
demonstrate parasympathetic dysfunction in modulating heart rate in diabetic 
patients. Longer recordings of blood pressure revealed sympathetic dysfunction 
in modulating peripheral vasculature. The ultimate goal of this study is to develop 
indexes of both sympathetic and parasympathetic function from noninvasive 
recordings taken over a short period of time. 
1.2.3 Models of Autonomic Failure 
Studies of sino-aortic denervated (SAD) animals (cats and dogs), a form of 
‘dysautonomia’, showed that not only were harmonic components (LF or HF 
peaks) of heart rate and blood pressure oscillations affected by SAD, but 
nonharmonic components were also altered over a wide frequency range (very 
low, low and high frequencies) (29, 133). In addition to the alteration in heart and 
blood pressure variability over a wide  frequency range, the baroreflex 
effectiveness index, which represents the percentage of systolic blood pressure 
(SBP) ramps followed by reflex RR interval responses to all SBP ramps, was 
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reduced by 89% in SAD cats (31). In humans with pure autonomic failure, heart 
rate and blood pressure variability have been shown to be altered at all 
frequencies (97).  Finally, we reported previously that spinal cord injury resulted 
in reduced baroreflex effectiveness index in tetraplegic patients compared to able 
bodied controls (5). Results of these previous human and animal studies 
indicated similarities between diabetic autonomic neuropathy, sinoaortic 
denervation and primary autonomic failure that appeared to be proportional to the 
level of neuropathy and observable in noninvasive indexes of autonomic function. 
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1.3 Chapter Three: Methods 
1.3.1 Subjects 
Twelve healthy able-bodied volunteers (AB) were recruited from the local 
community using word of mouth, newspaper advertisements and flyers mounted 
on boards across the university campus and hospital. Twenty-two diabetic 
subjects were recruited.  The diabetic subjects were evaluated at the day of 
study by Dr. Kevin Nelson, Department of Neurology, UK College of Medicine, for 
distal symmetrical polyneuropathy using neuropathic symptoms, depressed ankle 
reflexes, distal sensory loss, distal muscle weakness or atrophy, and nerve 
conduction studies (18). Subjects were then distinguished by consensus criteria 
that determined the likelihood of neuropathy using an ordinal scale from highest 
4 to lowest 1 (35). ‘Possible neuropathy’ was defined by a likelihood ranking of 
two or three, and ‘definite neuropathy’ by the likelihood of 4.  Diabetic subjects 
without neuropathy had no signs or symptoms of neuropathy, in addition to 
normal nerve conduction studies. Based upon the results of these evaluations 
the neuropathy of diabetic subjects was categorized as absent (D0), possible 
(D1) or definite (D2). In addition to the tests for peripheral neuropathy, and for 
fasting blood glucose levels on the day of study, all subjects underwent a 
familiarization tilt and 12 lead ECG. Medications affecting autonomic function 
were discontinued for the day of study. Demographic characteristics of the 
participants are shown in Table 1. 
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Table 1 Demographic characteristics of participants     
  Diabetic 
  
Able-
bodied 
(AB)                                     
No 
Peripheral 
Neuropathy 
(D0)
Possible 
Peripheral 
Neuropathy 
(D1) 
Definite 
Peripheral 
Neuropathy 
(D2) 
Age, yr 48.2 ± 3.9 39.7 ± 5.6 53 ± 4.1 55.1 ± 2.7 
Weight, kg 93.0 ± 9.0 84.2 ± 8.1 110.7 ± 15.9 97.9 ± 11.4 
Height, cm 171.5 ± 3.0 164.6 ± 3.0 176.8 ± 4.6 174.2 ± 3.3 
n (Male/Female) 12 (5/7) 7 (1/6) 7 (5/2) 8 (5/3) 
n of Type 1/ Type 2  3/4 2/5 3/5 
   Values are means ± SEM    
 
1.3.2 Tilt Protocol 
We utilized passive head-up tilt to challenge the autonomic regulation of 
arterial blood pressure.  Before entering the study all subjects gave written 
informed consent and the protocol was approved by the University of Kentucky 
Institutional Review Board. Prior to head-up tilt testing, subject’s height, age, 
weight and diabetic status were recorded. Later, after blood glucose level had 
been determined, an IV cannula was placed in an antecubital vein.  Subjects 
then rested in the supine position for 30 min when instrumentation was applied 
followed by 10 minutes of supine control and 30 minutes of 70-degree head-up 
tilt. If presyncopal symptoms developed during tilt, subjects were brought back to 
supine immediately. All subjects were followed for a supine recovery period of 
five minutes. 
1.3.3  Measured Variables 
Mixed venous blood samples were drawn from the antecubital vein 
catheter at the end of control, at three and seven min of tilt, and during the 
second minute of recovery. Results of blood assays, body fluid shifts and 
impedance measures of cardiac output are not reported here, but are 
components of the next manuscript, see Future Work. 
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Lead II ECG (Pilot Colin) was acquired from three electrodes. Noninvasive 
continuous arterial blood pressure (BP, Portapres model-2) was acquired from a 
cuff placed at finger. Respiratory activity (Respitrace) was acquired by measuring 
respiratory inductance plethysmography with two bands enclosed chest and 
abdomen. Two laser Doppler probes (Perimed) were placed at two skin sites: 
one on the palm of hand (non-hairy skin) and the other on the forearm (hairy 
skin). The measuring depth of the probe was 0.5 – 1 mm with the fiber separation 
0.25 mm and the wavelength of the laser 780 nm (77, 121).  Fluid shifts between 
body segments were assessed by measuring bio-impedance (UFI THRIM) of 
thorax, abdomen, upper leg and lower leg. Tilt angle (Crossbow CXL 04LP3) was 
acquired from an accelerometer mounted on the tilt table. Recordings were 
commenced during supine control, and continued uninterrupted during the 70 
degree head-up tilt and supine recovery. The blood pressure sensor was 
maintained at heart level.  Manual blood pressure using an arm cuff was 
acquired at the end of supine control, the beginning of tilt and at the end of 
recovery. The hand with blood pressure finger cuff and laser Doppler probe was 
covered by a mitten, in order to keep the hand warm and allow for a measurable 
blood pressure signal during the whole study. A 12-lead ECG was acquired from 
supine subjects breathing at 15 breaths/min. Data acquisition of 12-lead ECG 
lasted for approximately 5 min or until at least 256 heart beats were recorded for 
signal averaging. Room temperature was maintained at 22 ± 0.25oC (mean ± 
SEM), ranging from 20.6-23.9 oC.  
1.3.4 Data Acquisition and Analysis 
Blood pressure, ECG, respiratory activity, skin perfusion, bio-impedance 
and tilt angle recordings were digitized at 1000 Hz by using a commercial data 
acquisition system (DATAQ). 12-lead ECGs were digitized at 1000 Hz and 
recorded by using a commercial device and software (Cardiax). 
Mean values. Heart rate (HR) and RR interval were computed by 
identifying R waves in the last 5 min of control, 0-3 min, 3-7 min, and 7-12 min of 
tilt and the first 3 min of recovery. Data were analyzed using custom written 
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programs in C++ and MATLAB (the MathWorks, Natick, MA). Artifacts in HR and 
BP signals, including premature beats and Portapres servo adjustments 
(approximately 5% of the beats per time series), were manually removed. The 
cleaned signals were then aligned in time. Systolic (SBP) and diastolic (DBP) 
blood pressures were determined by computing the maximum and minimum 
values of clean arterial BP for each heart beat. Beat-to-beat skin perfusion 
sequences were determined by integrating the pulsatile skin perfusion between 
two R waves. Mean values of RR interval, SBP, DBP and skin perfusions of palm 
and forearm were computed in each time segment. All subsequent data analyses 
were performed in MATLAB.  
Spectral analysis. RR interval, SBP, DBP and skin perfusions in control, 
tilt and recovery periods were resampled at 4 Hz using a cubic spline. Power 
spectral densities of RR interval, SBP and DBP were analyzed in the last 5 min 
of control, 0-3 min, 3-7 min, and 7-12 min of tilt and the first 3 min of recovery. 
Power spectral densities of skin perfusions were analyzed in 10 min of control 
and the first 10 min of tilt to acquire a better accuracy at lower frequencies. Each 
segment was then linearly detrended. Power spectral densities were estimated 
using Welch's method of averaged periodograms (480-point Hamming windows 
with 440-point overlap). Spectral powers of RR interval, SBP and DBP in the LF 
(0.04-0.15 Hz) and HF (0.15-0.4 Hz) regions were obtained using trapezoidal 
integration over the specified frequency range. Spectral power of DBP was used 
as an index of sympathetic control of vasomotion because DBP correlated better 
than did SBP with vascular resistance (13). Power spectral density of SBP, 
however, was used as an index of baroreflex-mediated buffering of blood 
pressure. Power spectral densities were plotted in a log-power vs. log-frequency 
scale, and the slope of the linear regression of this plot within the LF range was 
calculated. This power law scaling relationship was quantified for RR interval, 
SBP and DBP to determine their harmonic and nonharmonic characteristics (34, 
50). The magnitudes of the power spectral density of skin perfusions were 
determined from the mean value of the logarithm of the power spectral density in 
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specific frequency regions: very low frequency (VLF, 0.004-0.04 Hz), low 
frequency (LF, 0.04 -0.15 Hz) and high frequency (HF, 0.15-0.4 Hz).  
        Coherences. The coherences between skin perfusions and blood pressure 
were analyzed across 10 min of control and the first 10 min of tilt. The 95% 
confidence level of non-zero coherence was estimated by the following method. 
If the theoretical coherence between the input and output signals of a linear time-
invariant system is zero, then the random variable 
(𝑣 − 2)𝑟𝑥𝑦2 (𝑓)
2(1 − 𝑟𝑥𝑦2 (𝑓))
 
is approximately distributed with an F distribution 𝑓2,𝑣−2, where r2xy is the squared 
coherence between skin perfusion and blood pressure, and 𝑣 is the degree of 
freedom associated with Hamming window, which was estimated by 
𝜈 = 2.51 𝑁
𝑀
. 
2M is the window length and N is the data length. Therefore, we have 
(𝑣−2)𝑟𝑥𝑦2 (𝑓)
2(1−𝑟𝑥𝑦2 (𝑓))
= 𝑓2,𝑣−2                    <1> 
Rearranging <1> and replacing the f function in <1> with its 95% critical value 
give the 95% confidence level of non-zero coherence as 
𝑟2 =
2𝑓2,𝑣−2(0.95)
(𝑣 − 2) + 2𝑓2,𝑣−2(0.95)
 
 
Because able-bodied subjects and diabetics without neuropathy had 
similar skin perfusion responses to head-up tilt, and diabetics with possible and 
those with definite neuropathy had similar responses, able-bodied subjects and 
diabetics without neuropathy were combined into one, non-neuropathy, group, 
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and diabetics with possible and those with definite neuropathy were combined 
into one neuropathy group. 
     Baroreflex sequences. The sequence method (12) was adopted to quantify 
the number of blood pressure ramps and baroreflex sequences, as well as 
baroreflex sensitivity. Sequences of three or more consecutive heartbeats were 
identified, in which progressively increasing (or decreasing) SBP with at least 1 
mmHg beat-to-beat change were followed within 1 heart beat by progressively 
lengthening (or shortening) of RR interval with at least 4 msec beat-to-beat 
change. A sequence was accepted as a baroreflex sequence if the correlation 
coefficient of the regression line between SBP and RR interval within the 
sequence was 0.85 or greater (12). The slope of the regression line for each 
sequence was taken as spontaneous baroreflex sensitivity (BRS). The ratio 
between the number of baroreflex sequences and the total number of increasing 
or decreasing SBP ramps determined the baroreflex effectiveness index (BEI) 
(31). Because the numbers of SBP ramps and baroreflex sequences depend on 
the number of analyzed heartbeats, which varied among and within subjects, the 
numbers of SBP ramps and baroreflex sequences were normalized by the 
number of analyzed heartbeats of each subject in each time segment. 
Arterial pulse transit time. An index of arterial compliance, arterial pulse 
transit time (PTT), was measured by adapting the technique of Foo et al. (42). 
Arterial PTT was recorded as the time interval between the R peak in ECG and 
the SBP peak in the arterial pressure measured at the finger. Average values 
from ten beats selected from clean data were taken in the last minute of supine 
control and the second minute of 70-degree head-up tilt. 
Statistical analysis.  SAS (The SAS Institute, Cary, NC) software was used 
to test a linear mixed model for differences within and among four groups (able-
bodied, diabetic without neuropathy, diabetic with possible neuropathy, diabetic 
with definite neuropathy) during supine control, at three time segments during tilt, 
and in recovery. The group factor was used to test differences among the four 
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groups. The time factor was used to test the tilt effect. The group × time factor 
was used to test for differences in tilt effects across groups. The changes from 
control to the first three minutes of tilt were tested with one-way ANOVA and two-
tail t tests. For a priori hypothesized differences between variables, for which we 
predicted a specific difference (greater or less) before we analyzed the data, 
changes from control were analyzed using one-tail t tests. Data were transformed 
by using logarithm or square root if the residual plots showed heteroscedasticity. 
Nonparametric test, the Mann-Whitney U test, was used to test the changes from 
supine control to tilt when the distribution of data did not meet the requirement of 
t test. Outliers were identified if residuals were larger than two standard 
deviations and thus were not included in the statistical testing. Differences were 
considered significant if p ≤ 0.05. Results are presented as mean ± SEM.  
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1.4 Chapter Four: Results 
Upon testing, one able-bodied subject was diagnosed with nondiabetic 
sensory and motor neuropathy; his data were not included in any group. Five 
able-bodied subjects, and three diabetics with possible neuropathy demonstrated 
symptoms of presyncope before finishing 30 min of head-up tilt and were 
returned to supine immediately. 
Typical RR interval, arterial BP, skin perfusion of palm and forearm, and tilt 
angle of an asymptomatic able-bodied subject and a diabetic patient with definite 
neuropathy during supine and during 30 min head-up tilt are shown in Figure 1.1. 
In the nonsyncopal, able bodied subject, RR interval decreased and BP 
increased modestly during head-up tilt. In the same subject, skin perfusion of 
palm increased and skin perfusion of forearm decreased during head-up tilt. In 
the diabetic patient with definite neuropathy, RRI decreased to a smaller extent 
and BP decreased during head-up tilt. In the same subject, skin perfusion of 
palm was higher than that in the able-bodied subject at control and did not 
increase during head-up tilt. Skin perfusion of forearm of this subject also 
decreased during head-up tilt. 
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Figure 1.1 Typical RR interval, arterial blood pressure and skin perfusions 
of palm and forearm during 10 min supine control, 30 min 70-degree head-
up tilt and 5 min recovery, in an able-bodied subject (left), and a diabetic 
subject with definite neuropathy (right). 
 
1.4.1 Mean Values 
Figure 1.2 shows group averaged (± SEM) RR interval and SBP for able-
bodied (AB; blue line) subjects, diabetics without neuropathy (D0; pink line), 
diabetics with possible neuropathy (D1; red line) and diabetics with definite 
neuropathy (D2; dark red line). Data are given for supine control, three stages of 
tilt and supine recovery. All groups decreased RR interval (Figure 1.2A) in 
response to head-up tilt. The magnitudes of SBP responses to the first three 
minutes of head-up tilt (Figure 1.2B2) were significantly different between able-
bodied subjects and diabetics with definite neuropathy (one-tailed t-test); for 
able-bodied, SBP increased from 124 ± 5.8 mmHg in supine control to 132 ± 7.9 
mmHg; for diabetics with definite neuropathy, SBP decreased from 128.7 ± 7.8 
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mmHg in supine control to 119.2 ± 10.7 mmHg. Supine control values of RR 
interval and SBP were not different between the groups.  
 
Figure 1.2 Average ± SEM RR interval (Figure A) and systolic blood 
pressure (Figure B1) for able-bodied subjects (AB; n=11), diabetics without 
neuropathy (D0; n=6), diabetics with possible neuropathy (D1; n=5) and 
diabetics with definite neuropathy (D2; n=8) in response to head up tilt. 
Figure B2 shows changes of SBP from supine control to the first 3 min of 
tilt. Δ, significantly different from control (same group); •, significantly 
different from AB (same time segment); *, significantly different from D0 
(same time segment). 
Figure 1.3 shows group averaged (± SEM) skin perfusion of the forearm 
for combined groups of subjects without neuropathy (able-bodied and diabetics 
without neuropathy) and those with neuropathy (diabetics with possible and 
definite neuropathy). Skin perfusion of forearm decreased in both groups (tilt 
main effect, p = 0.0078) during all time segments of head-up tilt compared to 
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control and recovery. The neuropathy group tended to have higher skin perfusion 
of forearm than the non-neuropathy group (group main effect, p = 0.189, Figure 
1.3). We interpret this tendency to be due to the larger number of male subjects 
in the neuropathy group compared to the non-neuropathy group (Figure 1.4). 
Male subjects had higher skin perfusion than did females in both groups at 
control (gender main effect P<0.05 in two-way ANOVA with the factors of gender 
and presence of neuropathy). 
 
 
Figure 1.3 Average ± SEM skin perfusion of the forearm in the non-
neuropathy group [able bodied (AB), diabetics without neuropathy (D0)], 
and the neuropathy group [diabetics with possible neuropathy (D1) and 
diabetics with definite neuropathy (D2)] during 5 min of supine control, 0-3 
min, 3-7 min, 7-12 min and the last 3 min of head-up tilt and during 3 min of 
supine recovery. 
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Figure 1.4 Gender differences in average ±SEM skin perfusion of the 
forearm in non-neuropathy (AB+D0, left) and neuropathy (D1+D2, right) 
groups during 5 min of supine control, 0-3 min, 3-7 min, 7-12 min and the 
last 3 min of head-up tilt and during 3 min of supine recovery. 
 
Figure 1.5 shows group averaged (± SEM) skin perfusion of the palm for 
combined non-neuropathy and neuropathy groups. Skin perfusion of palm was 
significantly higher in the neuropathy group than in the non-neuropathy group 
during supine control. Skin perfusion of the palm of the non-neuropathy group 
increased significantly after the third minute of head-up tilt, while skin perfusion of 
the palm of the neuropathy group decreased during the first 3 min of head-up tilt. 
During recovery, palmar skin perfusion of the non-neuropathy group was higher 
than control, while that of neuropathy group was not different from control. Group 
differences in response to head-up tilt are easier to see, when palmar skin 
perfusion is plotted as tilt-induced changes from control (Figure 1.6). The 
changes of palmar skin perfusion in the neuropathy group were significantly 
different from those in the non-neuropathy group after the third minute of head-up 
tilt and during recovery. When each group was further divided into male and 
female subjects, gender differences were not significant either in the control 
values or in the responses to head-up tilt (Figure 1.7). 
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Figure 1.5 Average ± SEM skin perfusion of the palm of the hand in the non-
neuropathy (AB and D0) and neuropathy (D1 and D2) groups during 5 min 
of supine control, 0-3 min, 3-7 min, 7-12 min and the last 3 min of head-up 
tilt and during 3 min of supine recovery. ●, significantly different between 
groups in the same time segment. Δ, significantly different from control in 
the same group. 
 
Figure 1.6 Average ± SEM changes from control of palmar skin perfusion 
for non-neuropathy (AB and D0) and neuropathy (D1 and D2) groups during 
0-3 min, 3-7 min, 7-12 min and the last 3 min of head-up tilt and during 3 
min of supine recovery. ●, significantly different between groups in the 
same time segment. Δ, significantly different from the first 3 min of tilt in 
the same group. 
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Figure 1.7 Gender differences in average ±SEM skin perfusion of the palm 
in non-neuropathy (AB+D0, left) and neuropathy (D1+D2, right) groups 
during 5 min of supine control, 0-3 min, 3-7 min, 7-12 min and the last 3 min 
of head-up tilt and during 3 min of supine recovery. 
 
1.4.2 Spectral Power 
Figure 1.8 gives average high frequency spectral power of RR interval 
(HFRRI, Panel A, left) and low frequency spectral power of diastolic blood 
pressure (LFDBP, Panel B1, upper right) for each of the four groups. In Figure 
1.8A, HFRRI decreased during head-up tilt for all groups. In addition, able-bodied 
subjects and diabetics without neuropathy had higher HFRRI than did diabetics 
with definite neuropathy (group main effect).  Figure 1.8B1 shows that diabetics 
with possible neuropathy and those with definite neuropathy tended to have 
lower LFDBP than did able-bodied subjects and diabetics without neuropathy 
during head-up tilt (group × time, p=0.06). The change in LFDBP during the first 
3 min of tilt, Figure 1.8B2, differed significantly (p<0.05) between able-bodied 
(2.1 ± 0.4 mmHg2 supine, to 4.9 ± 1.6 mmHg2) and diabetics with definite 
neuropathy (2.1 ± 0.5 mmHg2 supine, to 1.6 ± 0.7 mmHg2).  
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Figure 1.8 Panel A: Average ± SEM spectral power of RR interval in the 
high-frequency region for able-bodied subjects (AB; n = 11), diabetics 
without neuropathy (D0; n = 6), diabetics with possible neuropathy (D1; n=5) 
and diabetics with definite neuropathy (D2; n =8) at rest and in response to 
head-up tilt. Panel B1: The spectral power of DBP in the low-frequency 
region for the four groups in response to head-up tilt.  These group 
differences in response to the first 3 min of tilt are shown in Figure B2. •, 
significantly different from AB; *, significantly different from D0. 
 
Figure 1.9 shows group averaged log of power spectral density of SBP 
(PSD SBP; Figure 1.9A and Figure 1.9B, top) and log of RR interval (PSD RRI; 
Figure 1.9D and Figure 1.9E bottom) versus log of frequency for able-bodied 
subjects (left panels) and diabetics with definite peripheral neuropathy (middle 
panels).  The analyses are from recordings taken during five minutes of supine 
control. Data shown are means (solid lines) ± SEM (shaded area above and 
below the mean). Spectral power of SBP was significantly greater (four fold, 
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which is not immediately evident on logarithmic scales) in diabetics with definite 
neuropathy than in able-bodied subjects (Figure 1.9B vs. Figure 1.9A) across the 
very low frequency (0.003 - 0.04 Hz) and high frequency (0.15 - 0.4 Hz) regions. 
However, in contrast to able-bodied subjects, the SBP spectral power of 
diabetics with definite neuropathy dipped at frequencies around 0.1 Hz (Figure 
1.9B). In addition, the slope of the linear portion of this SBP curve in the low 
frequency region tended to be steeper in diabetics with definite neuropathy (-2.64 
± 0.44) than in able-bodied subjects (-1.54 ± 0.37) (Figure 4C). SBP powers for 
diabetics without, and those with, possible neuropathy, were similar to that of 
able-bodied subjects (not shown). In contrast to SBP, the variability of RR 
interval for diabetics with definite neuropathy was significantly (four fold) lower 
than that of able-bodied subjects over the range of frequencies (0.003 - 0.4 Hz) 
(Figure 1.9D vs. Figure 1.9E). Log-log plots of RRI for diabetics without 
neuropathy and diabetics with possible neuropathy were intermediate between 
able-bodied subjects and diabetics with definite neuropathy (not shown). Slopes 
of the log-log RR interval/frequency curve were significantly steeper in the low 
frequency region (0.04 - 0.15Hz) in diabetics with possible (-2.19 ± 0.35) and 
definite neuropathy (-2.77 ± 0.24) than slopes of able-bodied (-1.05 ± 0.35) and 
diabetics without neuropathy (-1.15 ± 0.4), Figure 1.9F.  
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Figure 1.9 Average ± SEM logarithm of power spectral density of systolic 
blood pressure (PSD SBP) and RR interval (PSD RRI) taken from 5 min 
supine control (means shown in solid lines and SEM shown in shaded area 
above and below the mean in A, B, D and E). Plots A and B show log (PSD 
SBP) vs log (f) for AB (n = 11) and D2 (n=8) respectively. Plot C shows the 
average value of the slopes of the linear portion  of log (PSD SBP) vs log (f) 
curves in the low frequency (0.04 - 0.15 Hz, LF) region for all four groups.  
Plots D and E show log (PSD RRI) vs log (f) for AB and D2 respectively. Plot 
F shows the average value of the slopes of log (PSD RRI) vs log  (f) curves 
in the low frequency. •, significantly different from AB; *, significantly 
different from D0. 
Figure 1.10 shows power spectral density (PSD) of diastolic blood 
pressure (DBP) on a logarithmic scale, during 10 min supine control (left panel) 
and the first 10 min of tilt (right panel) in non-neuropathy (blue) and neuropathy 
(red) groups. The PSD of DBP demonstrated similar response to that shown in 
Figure 1.8B, but with a more obvious difference between the two groups. During 
head-up tilt the mean magnitude of PSD in the low frequency region increased in 
the non-neuropathy group but did not change in the neuropathy group. In 
addition, mean LF PSD was lower in the neuropathy group than in the non-
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neuropathy group. High frequency PSD of DBP decreased from control to tilt in 
the neuropathy group. 
 
Figure 1.10 Average ± SEM logarithm of power spectral density of diastolic 
blood pressure taken from10 min supine control and the first 10 min of 
head-up tilt. ●, significantly different between groups in the same time 
segment. Δ, significantly different from control in the same group. 
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Figure 1.11 shows PSD of skin perfusion of the forearm on a logarithmic 
scale, during 10 min supine control (left panel) and the first 10 min of tilt (right 
panel) in non-neuropathy and neuropathy groups. Low frequency PSD 
decreased during tilt in the neuropathy group but did not change in the non-
neuropathy group (group × time interaction p=0.03). The changes of mean LF 
PSD of skin perfusion of the forearm from control to tilt are shown in Figure 1.12. 
The change of LF PSD was significantly different between the non-neuropathy 
and neuropathy groups (Mann-Whitney Test, p = 0.05). The group difference was 
more obvious in the frequency range between 0.075 and 0.1 Hz (time × group 
interaction, p= 0.02; the non-neuropathy group tended to be greater than the 
neuropathy group during tilt, p = 0.1). In the high frequency region, mean PSD in 
the neuropathy group was higher than that in the non-neuropathy group in control 
and decreased during tilt (Figure 1.11, group × time interaction, p=0.012). 
 
 
Figure 1.11 Average ± SEM logarithm of power spectral density of skin 
perfusion of forearm taken from10 min supine control and the first 10 min 
of head-up tilt. ●, significantly different between groups in the same time 
segment. Δ, significantly different from control in the same group. 
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Figure 1.12 Change of mean low frequency PSD of skin perfusion of the 
forearm from control to the first 10 min of head-up tilt. P = 0.05, Mann-
Whitney Test. 
Figure 1.13 shows the power spectral density of skin perfusion of palm on 
a logarithmic scale, during 10 min supine control and the first 10 min of tilt in non-
neuropathy and neuropathy groups. Mean magnitude of PSD in the very low 
frequency region decreased in both groups from control to tilt (main tilt effect). 
High frequency PSD tended to decrease in the neuropathy group but did not 
change in the non-neuropathy group (group × time interaction p=0.06). 
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Figure 1.13 Average ± SEM logarithm of power spectral density of skin 
perfusion of palm taken from10 min supine control and the first 10 min of 
head-up tilt. 
1.4.3 Coherences 
Coherences between skin perfusion of the forearm and SBP during 10 min 
supine control and 10 min tilt for non-neuropathy and neuropathy groups are 
shown in Figure 1.14. At control, coherences between skin perfusion and SBP in 
the low frequency region were significant in the non-neuropathy group and were 
at the borderline of significance in the neuropathy group. In response to tilt, 
coherences in the low frequency region increased in the non-neuropathy group 
but decreased in the neuropathy group. At respiratory frequencies, coherences 
were significant in the neuropathy group in control and tilt. In the non-neuropathy 
group, coherences at respiratory frequencies were not significant during control, 
but approached significance during tilt.  The responses were similar in the 
coherence between skin perfusion of forearm and DBP (Figure 1.15).  
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Figure 1.14 Average ± SEM coherence of skin perfusion of forearm and 
systolic blood pressure during 10 min supine control and the first 10 min of 
head-up tilt. Horizontal lines: 95% confidence level of non-zero coherence. 
 
 
Figure 1.15 Average ± SEM coherence of skin perfusion of forearm and 
diastolic blood pressure during 10 min supine control and the first 10 min 
of head-up tilt. Horizontal lines: 95% confidence level of non-zero 
coherence. 
The LF coherence between skin perfusion of the palm and SBP was not 
significant during supine control in both groups, but increased during tilt in the 
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non-neuropathy group. The LF coherence did not change in the neuropathy 
group (Figure 1.16). At respiratory frequencies, coherences were significant in 
the neuropathy group in control and tilt. In the non-neuropathy group, coherences 
at respiratory frequencies were not significant during control, but approached 
significance during tilt.  The responses were similar in the coherence between 
skin perfusion of palm and DBP (Figure 1.17). 
 
 
Figure 1.16 Average ± SEM coherence of skin perfusion of palm and 
systolic blood pressure during 10 min supine control and the first 10 min of 
head-up tilt. Horizontal lines: 95% confidence level of non-zero coherence. 
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Figure 1.17 Average ± SEM coherence of skin perfusion of palm and 
diastolic blood pressure during 10 min supine control and the first 10 min 
of head-up tilt. Horizontal lines: 95% confidence level of non-zero 
coherence. 
1.4.4 Baroreflex Sequences 
Figure 1.18 provides the normalized number of SBP ramps (A), 
normalized number of baroreflex sequences (B), baroreflex effectiveness index 
(BEI; C), baroreflex slope (D) and high frequency spectral power of systolic blood 
pressure (HFSBP; E) for each of the four groups. In supine control, both 
diabetics with possible, and those with definite, neuropathy had greater numbers 
of SBP ramps than did able-bodied subjects (Figure 1.18A). During head-up tilt, 
diabetics with definite neuropathy also had more SBP ramps than did diabetics 
without neuropathy during all three time segments, most clearly illustrated at 7-12 
min of tilt. However, diabetics with definite neuropathy had a significantly smaller 
number of baroreflex sequences than did able-bodied subjects and diabetics 
without neuropathy (group main effect; Figure 1.18B). As a result, BEI values for 
diabetics with possible, and for those with definite, neuropathy were significantly 
lower than those for able-bodied subjects and diabetics without neuropathy 
during head-up tilt (Figure 1.18C). One able-bodied subject had BEI residuals 
larger than 2 standard deviations at all time segments. When this subject’s data 
were excluded from the analysis, the group x time interaction became significant. 
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Other factors remained significant with or without exclusion of this subject, with 
no effect on the direction of the results. In addition, baroreflex slope significantly 
decreased in all groups in response to head-up tilt (Figure 1.18D). Diabetics with 
possible neuropathy had significantly lower baroreflex slopes than able-bodied 
subjects, and diabetics with definite neuropathy had significantly lower slopes 
than both able-bodied subjects and diabetics without neuropathy (group main 
effect). Finally, the diminution of baroreflex activity to buffer breathing frequency 
blood pressure oscillations in diabetics with definite neuropathy is illustrated in 
Figure 1.18E indicating a four fold greater magnitude of HFSBP oscillations in 
those subjects compared to the other groups (similar to the results illustrated in 
Figure 1.9 A and B).  
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Figure 1.18 Baroreflex regulation: Average ± SEM normalized number of 
SBP ramps (A), normalized number of baroreflex sequences (B), baroreflex 
effectiveness index (C), baroreflex slope (D), and high frequency spectral 
power of SBP (E) for AB (n = 11), D0 (n=6), D1 (n=5) and D2 (n=8) at rest and 
in response to head-up tilt. Δ, significantly different from control (same 
group); •, significantly different from AB (same time segment); *, 
significantly different from D0 (same time segment). 
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1.4.5 Gender 
Because of known gender differences in autonomic regulation of heart 
rate (parasympathetic dominance in high frequency power of heart rate in women 
compared to men) and peripheral vasculature (sympathetic dominance in control 
of vascular regulation in men)  (7, 37, 52, 80), we examined heart rate, blood 
pressure and baroreflex variables for gender differences. The results of these 
analyses indicated that, for these groups, gender effects were obscured by 
effects of diabetes (data not shown).   
1.4.6 Arterial Pulse Transit Time (PTT) 
Arterial PTT was not significantly different among the four groups in supine 
or during the second minute of tilt, nor the tilt-induced increases of PTT were 
significantly different among the four groups. 
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1.5 Chapter Five: Discussion 
1.5.1 Mean Values of Blood Pressure and RR Interval 
The inability of diabetics to increase, or even maintain, blood pressure 
during tilt (Figure 1.2), indicated that sympathetic pathways to cardiovascular 
effectors were impaired in diabetics with peripheral neuropathy compared to 
able-bodied subjects. In healthy humans, orthostatic stress induces 
vasoconstriction at the arteriolar level, which increases absorption of fluid into the 
plasma. The drop of blood pressure in diabetic patients with definite neuropathy, 
and the lack of increase of blood pressure in diabetic patients without or with mild 
neuropathy during the first three minutes of tilt, may reflect impairment of normal 
orthostatic vasoconstriction (109). Moreover, the importance of the baroreflex in 
regulating blood pressure over longer time periods is illustrated in the very low 
frequency region of Figure 1.9. These results also support the comment made by 
many of the patients that they had learned to move slowly into the upright 
position and if they move slowly they are okay. The slow speed (approximately 
38 seconds to move from supine to 70 degrees head up) of our tilt was probably 
responsible for the fact that presyncopal symptoms were relatively rare in our 
diabetic subjects.    
1.5.2 Mean Values of Skin Perfusion 
In all subjects, the skin perfusion of the palm was higher than that of the 
forearm as expected (62), an effect related to the presence of arteriovenous 
anastomoses in the microcirculation of the non-hairy skin (79). A higher 
evaporation rate from the skin of the palm of hand than that from the forearm at a 
thermoneutral environment has also been reported (57). 
In the current study, in response to head-up tilt, the skin perfusion of the 
forearm decreased in the subjects without neuropathy, as expected (4, 62, 84, 
109, 111, 117).  The neuropathy group had similar responses to head-up tilt 
compared to the non-neuropathy group, indicating a normal reflex adrenergic 
control of cutaneous vasoconstriction, or the withdrawal of cholinergic control of 
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vasodilation in the forearm, in the neuropathy group (58). However, the 
neuropathy group tended to have a greater skin perfusion of the forearm at all 
time segments. This was probably due to a larger number of male subjects in this 
group compared to the non-neuropathy group, since men tended to have higher 
skin perfusion than did women in both groups as shown in Figure 1.4.   
In the palm, the mean skin perfusion in the non-neuropathy group did not 
change during the first 3 min of head-up tilt (Figure 1.1), supporting the absence 
of vasoconstriction in the hand during orthostasis (109). It was also reported that 
direct baroreflex stimulations on carotid sinus nerve did not have discernible 
effect on the outflow of the skin sympathetic nerve (134). In the present study, 
the unchanged skin perfusion of the palm during the first 3 min of head-up tilt 
may be due to a lack of increase in sympathetic outflow during orthostasis. After 
the first 3 min of head-up tilt, skin perfusion of the palm increased in the non-
neuropathy group (Error! Reference source not found., Figure 1.6). We 
interpret this increase to be due to an increase of core temperature, previously 
observed in both men and women during graded head-up tilt to 60 degrees (84). 
Therefore, vasoconstriction of hairy skin during head-up tilt (Figure 1.3) appears 
to be acting to prevent heat loss (109).  If core temperature increases, as a result 
of hairy skin vasoconstriction to preserve blood pressure,  the vasomotor drive to 
AVAs from the hypothalamus could be reduced and thereby provide a 
mechanism to shunt blood to the skin for cooling through AVA dilation, increasing 
blood flow and allowing heat dissipation (109). This hypothesis is consistent with 
our observations from the non-neuropathy group. Alternatively, or in addition to 
prevention of heat loss, metabolic rate has been shown to rise during head up tilt 
(20). 
Johnson et al. (65) have shown that adrenergic blockade by bretylium 
increased baseline palmar skin blood flow. In patients with familial dysautonomia, 
baseline skin blood flow at finger pulp tended to be higher than that in healthy 
subjects (121). This study also reported that sinusoidal neck suction at 0.1 Hz 
caused reduction in skin blood flow at finger pulp in healthy control subjects, 
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while the reduction of pulpar finger blood flow was much smaller in patients with 
familial dysautonomia (121). In our study, elevated control values of palmar skin 
perfusion in the neuropathy group, compared to the non-neuropathy group, may 
reflect impaired tonic sympathetic control of vasoconstriction of palmar skin in 
patients with neuropathy. During head-up tilt, the different palmar skin perfusion 
responses between the two groups appears to indicate an abnormal function of 
heat dissipation via opening AVAs in the neuropathy group. It is known that 
palmar skin lacks active vasodilation (65). In our study, the absence of tilt-
induced increase of skin perfusion of the palm in the neuropathy group 
suggested a loss of tonic vasoconstriction at rest and an impaired ability to 
increase blood flow by withdrawal of vasoconstriction of the palmar skin. 
1.5.3 RR Interval Spectral Power Indexes of Sympathetic and 
Parasympathetic Control of Heart Rate 
The magnitude of the RR interval harmonic component at respiratory 
frequencies (HFRRI) is a marker of vagal control of the SA-node (101). The rapid 
decline of HFRRI in response to head-up tilt and rapid recovery of HFRRI when 
AB subjects were returned to supine (within a minute of the change in posture, 
Figure 1.8A) supports neural, reflex- mediated modulation of HR at respiratory 
frequencies in these people. During supine rest and head-up tilt, diabetics with 
definite neuropathy had lower HFRRI than did able-bodied subjects or diabetics 
without neuropathy, indicating impaired parasympathetic control of HR in 
diabetics with signs of peripheral neuropathy (124). The reduced reserve of 
parasympathetic control of HR in response to head-up tilt in diabetics with 
possible or definite neuropathy also confirmed a diminished orthostatic response 
and progressive loss of parasympathetic control of heart rate with increasing 
neuropathy (97). 
A previous study of sino-aortic denervated (SAD) cats determined that the 
wide band spectra of pulse interval was significantly lower in SAD cats than that 
in controls (29). In our study, the decreases of wide band RR interval spectra in 
diabetics with definite neuropathy may be due to diminished baroreflex function, 
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or perhaps more specifically, to cardiac parasympathetic neuropathy. Moreover, 
the LF RRI component was different in diabetics with definite neuropathy:  a 
steeper slope of the 1/f relationship was evident at the LF range of diabetics with 
definite neuropathy. This 1/f relationship of power spectrum exists in dynamic 
systems that have multiple control mechanisms with different time constants and 
the steeper slope of the 1/f relationship suggests a less complex control system 
(15, 16, 50, 133) in diabetics with definite neuropathy.  If so, the complexity of the 
sympathetic regulation of heart rate in diabetics with definite neuropathy was 
diminished, possibly reflecting a diminution of sympathetic regulation of the SA 
node, perhaps secondary to diabetic sympathetic neuropathy. In patients with 
Chagas disease, which damages autonomic neurons, the slope of the linear part 
of the log-log plot of PSD RRI was significantly steeper than that of controls, 
indicating dysautonomia in these patients (27, 107). Therefore, the slope of log-
log plot of heart rate power spectral density of resting diabetic subjects calculated 
from a five-minute measurement appears to be a sensitive discriminator of 
autonomic neuropathy in the LF region. 
1.5.4 Blood Pressure Spectral Power Index of Sympathetic Control of 
Peripheral Vasculature 
Significant coherence between low frequency spectral power of diastolic 
blood pressure (LFDBP) and muscle sympathetic nerve activity has been 
reported in able-bodied humans (25). In particular, muscle sympathetic nerve 
activity increased with head-up tilt and remained elevated during tilt in able-
bodied subjects (46).  In our study, LFDBP increased in response to tilt and 
remained high in able-bodied and in diabetic subjects without neuropathy (Figure 
1.8B). Conversely, in diabetics with possible, and those with definite, neuropathy, 
LFDBP did not change indicating that reflex-mediated sympathetic pathways to 
peripheral vasculature were impaired in diabetics, including those with milder 
symptoms of neuropathy.  
The log-log plot (Figure 1.9A, B) of the power spectral density of systolic 
blood pressure (PSD SBP) taken during five minutes of supine rest, showed a 
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significant elevation of harmonic and nonharmonic components of blood pressure 
variability in the VLF and the HF regions but not in the LF range (presumably 
because of a loss of the harmonic component) in diabetics with definite 
neuropathy compared to able bodied subjects. These findings confirm the 
previously reported reduction of sympathetically mediated harmonic vasomotion 
in diabetic autonomic neuropathy (32, 144).    
1.5.5 Dynamics of Skin Perfusion 
The measured skin perfusion using laser Doppler technique is mainly from 
capillaries and post-capillary venules of the upper horizontal plexus. These 
vessels exhibit little variation in their diameter and thus have little contribution to 
the rhythmic change in skin perfusion. Oscillations in skin perfusion are probably 
related to constriction/dilation of upstream arterioles (23). The origin of the 
vasomotion of skin blood flow was believed to be a combination of central/neural 
and local/myogenic mediated mechanisms (119). The known impairment of 
vasomotion of skin perfusion in diabetics was considered to be due to nerve 
dysfunction, vascular abnormalities, or both (119). In the current study, the 
comparison of the dynamics of skin perfusion between diabetics without and 
those with neuropathy during supine control and head-up tilt in a thermoneutral 
environment, allowed us to explore neural origins of skin perfusion oscillations 
and effect of diabetic neuropathy on reflex control of skin perfusion under 
orthostatic stress. 
It was reported that  passive change in posture increased the cross-
correlation between skin blood flow (volar surface of the forearm) and heart rate, 
in which the maximum correlation during upright posture was always due to 
oscillations in the range of 0.1 Hz (10). In the same study, sympathetic blockade 
reduced the cross-correlation between skin blood flow and heart rate (10).  Our 
study support the influences of central autonomic control on skin blood circulation 
via demonstrating significant coherence between skin perfusion of the forearm 
and blood pressure in the LF region in subjects without neuropathy. The LF 
coherence increased in response to tilt in the subjects without neuropathy, but 
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decreased in those with neuropathy. This group difference indicated an impaired 
central autonomic control of skin perfusion in diabetics with neuropathy.  
In our study, the group difference in LF power spectral density of skin 
perfusion of the forearm was not significant during supine control, but became 
significant during head-up tilt, supporting the reduction of vasomotion in diabetic 
patients with neuropathy (85). Bernardi et al reported that, when supine, there 
was a significant difference in the LF skin blood flow oscillations in the forearm 
between diabetic patients and able-bodied subjects, with the magnitude of 
oscillations smaller in diabetics (11). However, in our study, the group difference 
was significant during tilt but not during supine control, which may due to an age 
difference between our able-bodied subjects and those in the study by Bernardi 
et al (48 vs. 38 yrs),  which had a known effect on the dynamics of skin perfusion 
(11).  
At the respiratory frequencies, the mean PSD of skin perfusion of the 
forearm was greater in the neuropathy group than in the non-neuropathy group, 
at supine control. It has been reported that respiratory oscillations is passively 
transmitted from blood pressure to skin blood flow (9). In our study, the elevated 
PSD of skin perfusion of forearm at respiratory frequencies in subjects with 
neuropathy may be due to elevated blood pressure oscillations in these subjects.  
Bernardi et al have reported that HF PSD of the skin perfusion of the forearm 
was not different between diabetics and able-bodied subjects (11). This 
discrepancy of HF PSD of skin perfusion between our and their studies may, 
again, be due to a difference in age (~10 yrs older in our study) or breathing 
patterns (spontaneous in our study vs. controlled breathing in that of Bernardi et 
al). Controlled breathing may have effects on HF PSD of skin perfusion, since 
controlled breathing reduced cardiac parasympathetic influences (102). 
Similar to the skin blood flow of the forearm, in the palmar skin, 
sympathetic nerve stimulation caused high-power peaks in the palmar skin blood 
flow oscillations in healthy human, between 0.025 to 0.1 Hz, with the maximum 
response within 0.075 - 0.1 Hz (120).  In our study, the LF coherence between 
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palmar skin perfusion and blood pressure became significant during head-up tilt 
confirming a central sympathetic control of skin blood circulation (8, 9). In our 
diabetics with neuropathy, the tilt-induced increase in LF coherence was not 
observed, indicating an impaired central sympathetic control of peripheral 
vasomotion. Significant LF coherences between skin blood flow (volar surface of 
the finger) and blood pressure during supine was reported (8, 9). However, in our 
study, the coherence between palmar skin perfusion and blood pressure at LF 
was not significant during supine control in the non-neuropathy group. This may 
due to the difference in the age of subjects (26 and 31 yrs in the previous studies 
vs. 45 yrs in our able-bodied subjects and diabetics without neuropathy), or the 
difference in the location of skin (finger vs. palm).  
In our study, the mean LF power spectral density of palmar skin perfusion 
in the non-neuropathy group did not increased in response to head-up tilt, in 
contrast to the standing-induced increase in LF power of skin at fingertip in a 
previous study (9). This discrepancy may due to the difference in the location of 
the skin (fingertip vs. palm). The location of the measured skin may also explain 
the absence of group difference in LF PSD of palmar skin perfusion during 
supine control in our study, contrary to the reduction of oscillation below 0.1 Hz in 
skin blood flow at pulpar surface of the index finger, in diabetics with neuropathy 
(119).  
Altered skin blood flow in diabetic patients could interfere with nutrient 
supply, causing ulcers and gangrene (131). Our diabetic subjects did not 
demonstrate these symptoms. However, autonomic regulation of skin perfusion 
was impaired in these subjects. Manifestation of dysfunction in skin perfusion 
regulation could occur earlier than symptoms of skin diseases in diabetic patients. 
1.5.6 Baroreflex 
The greater numbers of blood pressure ramps at rest and during tilt in 
diabetics with definite and suspected autonomic neuropathy (Figure 1.18A), was 
an unexpected finding of the present study. The combination of increased 
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numbers of BP ramps with reduced numbers of baroreflex sequences (44, 144), 
suggests that diabetics with neuropathy experience diminished effectiveness of 
the baroreflex in driving the sinus node. As is clearly illustrated in Figure 1.18C: 
BEI was significantly increased compared to supine control in able-bodied 
subjects during all phases of head-up tilt and in diabetics without neuropathy 
during 7-12 min of tilt, but remained unchanged in diabetics with possible, or 
definite, neuropathy. Further, Figure 1.18 clearly illustrates the ability of this 
measure to differentiate diabetics with neuropathy (definite or possible) from 
diabetics without neuropathy. Therefore, in our study, BEI was the most sensitive 
discriminator of neuropathy. Other studies have proposed LF power of SBP (32) 
as a sensitive discriminator of AN, but for our study, BEI was significantly better 
at discriminating differences, perhaps because this measure combines loss of 
sympathetic modulation of vasomotion with loss of parasympathetic control of 
heart rate into one parameter. Previous studies showed a severe impairment of 
baroreflex effectiveness in diabetic chronic renal failure patients compared with 
non-diabetic patients at supine rest (64). However, as far as we can determine, 
the present study is the first to demonstrate a reduction in baroreflex 
effectiveness in diabetics with neuropathy, without the simultaneous complication 
of chronic renal failure. 
Baroreflex sequences may reflect physiological activities in a portion of 
these sequences. Baroreflex effectiveness index was 33% in intact cats and 4% 
in sinoaortic denervated cats (31). Therefore, in cats, the number of sequences 
due to physiological mechanisms was 29% of that of SBP ramps. Similarly, in our 
study, BEI was 26% in healthy subjects, and 9.4% in diabetics with severe 
neuropathy, during supine control. Therefore, in human, the number of 
sequences due to physiological mechanisms was 16.6% of that of SBP ramps. In 
addition, BEI increased in healthy subjects in response to head-up tilt, but did not 
change in diabetics with neuropathy in our study. Therefore, baroreflex may be 
engaged in a part of blood pressure regulation if it is measured by using the 
baroreflex sequences technique. Baroreflex may be important in maintaining 
homeostasis because the VLF and HF PSD of SBP were four fold higher, while 
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the VLF, LF and HF PSD of RRI was four fold lower in diabetics with severe 
neuropathy, compared to able-bodied subjects during supine control. Therefore, 
BEI may reflect a fast response, while baroreflex is engaged at all frequencies. 
      Baroreflex sensitivity has been proposed to reflect the strength of the 
baroreflex when it is effective (31). In our study, all groups demonstrated 
decreased baroreflex slope in response to head-up tilt (Figure 5D) as expected 
(67, 95, 96).  However during both supine control and head-up tilt, diabetics with 
definite neuropathy had significantly smaller BRS than did able-bodied subjects 
and diabetics without neuropathy. During supine rest, diabetics without 
neuropathy tended to have smaller BRS than able-bodied subjects and larger 
BRS than diabetics with definite neuropathy. These findings support the widely 
held notion that diabetes reduces BRS and that reduced BRS is an early sign of 
AN (44, 104, 144). When we compared our significant reduction of BRS and BEI 
to the trend towards greater arterial pulse transit time in diabetics with definite 
neuropathy, we conclude that, for our study, baroreflex impairment was a more 
sensitive indicator of neuropathy than alterations in arterial stiffness (110). 
      Increased BP variability has been shown to predict nephropathy and 
retinopathy (71), and to correlate with endothelial and cardiovascular damage (28, 
141) and higher mortality (70). Blood pressure variability, measured by standard 
deviation over 24 h, has been reported to be significantly higher in diabetic 
patients (43, 61, 87, 135) and was highest in those with cardiovascular 
autonomic neuropathy (24). In our study, we further explored the specific 
frequency ranges of increased BP variability and determined that diabetics with 
definite neuropathy had significantly higher VLF and HF power spectral density of 
SBP compared with able-bodied subjects.  In addition, in all frequency ranges, 
our able bodied subjects demonstrated an ability to engage heart rate to buffer 
SBP fluctuations while diabetics with neuropathy demonstrated a reduced ability.  
       Arterial baroreflex buffering at respiratory frequencies may be more 
dominant in older persons. The fact that HF power of SBP was greater in our 
diabetics with neuropathy than in able-bodied subjects, but has been shown to 
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be smaller in diabetic children and adolescents than in healthy controls (72), may 
be a matter of age, but may, more accurately,  reflect the presence of neuropathy 
in our subjects. In addition, in middle-aged to older diabetics, HF power of SBP 
was reported to be smaller than in able-bodied during conditions of controlled 
breathing (32). The act of controlling breathing itself, however, may be 
responsible for this effect since it was previously determined that controlled 
breathing reduced cardiovascular parasympathetic influence (102). 
      An important indicator of impaired baroreflex-buffering of BP lies in the four-
fold increase in the harmonic and nonharmonic components of VLF power 
spectral density of SBP in diabetics with definite neuropathy compared with able-
bodied subjects (Figure 1.9A, B). Although enhanced VLF SBP has been 
reported to result from SAD in animals (19, 30), VLF SBP power in humans is 
believed to reflect renin-angiotensin system activity, endothelial factors and 
thermoregulation (101). However, in patients with primary autonomic failure, 
enhanced VLF oscillations of SBP have been documented (97). Our study’s 
enhanced VLF SBP power and decreased VLF RR interval power in diabetics 
with definite neuropathy, indicated that intact baroreflex function is important for 
normal BP regulation in the VLF range for both harmonic and nonharmonic 
components in able-bodied humans. Finally, in our study, VLF SBP was similar 
between able bodied and diabetics without neuropathy. This phenomenon has 
been reported previously in children and adolescents with Type 1 diabetes 
mellitus who have not developed other signs of neuropathy (72). These results 
suggest that in addition to BEI, increased VLF SBP spectral power may be a 
strong, early, indicator of diabetic neuropathy. 
      Our study did not show significantly increased standard deviation of SBP in 
diabetics with neuropathy. Similar to the finding of Frattola et al.(44), this may be 
due to the relatively short period of time over which the standard deviation was 
calculated (3 - 5 min in our study and 15 min in the study by Frattola et al.) 
compared to the greater standard deviation measured from  24h recordings (24, 
43, 61, 87, 135).   
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      At frequencies centered around 0.1 Hz (Figure 4B), the log-log power 
spectral density curve of SBP of diabetics with definite neuropathy demonstrated 
a dip, indicating that the loss of the harmonic component at LF (Fig 3B) is 
apparent in the log-log plot of SBP. This loss of power in the LF region is similar 
to that  previously reported following sino-aortic denervation in animals (29, 132) 
and total autonomic failure in humans (97). Sympathetic nerve activity (SNA) with 
a frequency around 0.1 Hz in man is similar to the 0.4 Hz rhythm in rat and, at 
this frequency, there is a tight coherence in unanesthetized rat between changes 
in SNA and changes in arterial BP (14). We conclude that the dip in oscillations 
of SBP in the LF region of diabetics with definite neuropathy is consistent with 
effects of neuropathy on sympathetically mediated vasomotion.  This change is 
exposed by the corresponding loss of parasympathetically (baroreflex) -driven 
changes in heart rate in subjects with definite neuropathy. In addition, altered BP 
and RR interval power spectral densities over the range of frequencies between 
0.003 and 0.45 Hz in diabetics with neuropathy indicate that an intact baroreflex 
is an important component of  healthy human BP regulation at all frequencies. 
Each of these measures is relatively easy to determine from a short (five minute) 
recording of continuous blood pressure and heart rate from resting subjects. 
1.5.7 Limitations 
The time of onset, the prevalence and the development of diabetic 
neuropathy, and treatment effects have been reported to be different between 
Type 1 and Type 2 diabetes (130, 142). Because of our limited number of 
subjects, diabetic patients were not separated based on the type of diabetes. 
Therefore the relative ability of our indices of autonomic dysfunction to identify 
autonomic neuropathy in Type 1 vs. Type 2 diabetes is unknown. Direct 
measures of sympathetic autonomic function (like MIBG SPECT imaging) were 
not performed, thus comparisons between direct measures and our indices are 
not available. Again, because of the limited numbers of subjects in each group, 
we were not able to establish age effects on the autonomic indices we report. 
The D0 group was younger than the D2 group; however, major differences in this 
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study lay between AB and D2 groups where there was no meaningful difference 
in age. Greater numbers of subjects would be required to establish significant 
interactions of study variables with gender and age.  
      The rate of presyncope (5 of 11) in the able-bodied subjects of the present 
study was similar to the able-bodied subjects that have reported by our lab in the 
past (78). In that study, 8 of 16 controls had symptoms within 30 minutes of 
head-up tilt. In another recent study of subjects who underwent 70-degree head-
up tilt, 56% (9 of 16) had presyncopal symptoms during the 30 min tilt (36). 
Results from a third study of head-up tilt-mediated presyncope in healthy humans 
suggested that unexplained syncope was a result of altered cardiorespiratory 
interaction involving cerebral hemodynamics but with a normal neural control 
system (73). Similar to our results, other investigators have determined that the 
initial response to head-up tilt was similar between patients with vasovagal 
syncope and nonsyncopal subjects, and sympathetic nerve activity withdrawal 
did not occur until symptoms began (88). We do not believe that the incidence of 
presyncopal events in the AB subjects is remarkable, nor does it call into 
question any aspect of the interpretation of our findings.  
      Finally,  abnormal findings in the battery of Ewing tests have been reported in 
13% of the normal population (99). In our study, two able-bodied subjects with 
tingling of hands and/or feet were found to be free of peripheral neuropathy by 
standard clinical tests. Both subjects, however, decreased their BEI to near 0% in 
response to tilt while other able-bodied subjects increased or maintained their 
BEI at greater than 10%.  In the group of diabetics with definite neuropathy, 6 of 
8 subjects had BEI smaller than 10%. The similar behavior of the two able-
bodied subjects to the behavior of the six diabetics with definite peripheral 
neuropathy suggests that BEI during tilt may be an index of autonomic 
neuropathy that is more sensitive, and/or more selective for autonomic 
involvement than are standard sensory/motor neuropathy findings. Also for other 
variables, when we removed these two subjects from the able-bodied group, the 
statistical significance of the group differences reported here were dramatically 
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increased, but without a physiological reason to remove them, the results 
reported here include these subjects with the able-bodied group.  
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1.6 Chapter Six: Conclusions 
The much reduced ability to regulate blood pressure, characterized by 
decreased RRI buffering of an increased number of SBP ramps, the four-fold  
increases in VLF and HF SBP power spectral densities and the four-fold 
decrease in VLF, LF and HF RR interval power spectral densities indicated 
serious deficits in maintenance of cardiovascular homeostasis in diabetics with 
neuropathy. The major contributor to this loss of blood pressure regulation 
appeared to be the combination of a loss of sympathetically mediated control of 
vasomotion, with a reduced contribution from parasympathetically mediated 
responses of heart rate to buffer these changes in blood pressure. Our results 
indicate that preservation of baroreflex function needs to become a focus of 
diabetic neuropathy treatment. The present study also indicates that, in healthy 
subjects, baroreflex function is an important component of blood pressure 
regulation in all (very low, low and high) frequency regions and pertains to both 
self-similar as well as harmonic components. In addition, sympathetic control of 
skin perfusion was impaired in diabetic patients with neuropathy, which 
manifested earlier than signs of skin diseases.  Finally, the results of our study 
indicate that noninvasive indexes of autonomic regulation were able to 
discriminate diabetics with autonomic neuropathy from subjects with reduced, or 
no, neuropathic damage. 
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1.7 Chapter Seven: Future Work 
The measurement of plasma volume and hormone levels from blood 
samples, as well as stroke volume from bio-impedance will give further indication 
of blood pressure regulation by fluid shift, hormones and cardiac function. In 
addition, phase analysis of the time relationship between oscillations of skin 
perfusion and blood pressure will provide further information on mechanisms of 
reflex control of skin blood flow. These data are available for analysis and 
therefore will be included in the next manuscript which will be focused on group 
differences in distribution of blood flow and hormonal responses during the 
orthostatic stress. 
In order to compare our noninvasive indexes with standard tests, 
comparisons to Ewing tests and MIBG-SPECT image need to be made to 
correlate these indexes with current clinical diagnoses of autonomic neuropathy 
and the gold standard method of detection of autonomic neuropathy to the 
myocardium. These comparisons have been, and will be, the topic of proposals 
submitted to extramural funding agencies.  
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Part 2. Four-dimensional multiscale model of ECG 
indexes of diabetics with autonomic neuropathy 
2.1 Chapter One: Introduction 
Prolongation of heart-rate corrected QT (QTc) interval of the ECG is well 
known in diabetic patients with autonomic neuropathy, and is correlated with the 
extent of autonomic neuropathy (51, 69, 83, 100, 125). Prolongation of QTc is 
associated with the risk of dying unexpectedly in diabetic patients with autonomic 
neuropathy (38) , and predicts long-term cardiac death in patients with non-
insulin dependent diabetes mellitus (17, 81, 90, 106), and insulin dependent 
diabetes mellitus (108, 127). However, the mechanism of QTc prolongation in 
diabetic patients with autonomic neuropathy is still unknown. QTc interval 
prolongation does reflect an alteration of myocardial repolarization (137). Direct 
comparison of maximal QTc interval and global or visual defects in patterns of 
myocardial MIBG uptake in diabetic patients demonstrated a relationship 
between QTc interval and regional cardiac sympathetic denervation (74). The 
aims of this part of the study are to 1) verify that the QT interval prolongation in 
our diabetic patients were similar to the prolongation reported in previous studies 
and 2) link QT interval prolongation to regional cardiac sympathetic denervation, 
at the cellular level using a computer heart-torso model. 
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2.2 Chapter Two: Background  
2.2.1 Cellular Basis of Autonomic Control of Ventricular Repolarization  
Sympathetic stimulation increases the contractility and rate of relaxation of 
the heart (79). In normal heart ventricles, postganglionic sympathetic fibers 
release the neurotransmitter norepinephrine which binds to β-adrenergic receptor 
on the cell membrane of myocytes.  One subtype of β-adrenergic receptor, the 
β1-receptor dominates in ventricular myocytes (79). β1-receptor stimulation 
activates the cAMP-dependent PKA pathway, resulting in an increase in L-type 
calcium current through Cav1.2 channels and a faster rate of closure of the 
channels through negative feedback (145). In addition, β1-receptor stimulation 
augments potassium current through the slowly activating, delayed-rectifier, 
potassium channel. This activation results in the shortening of cardiac action 
potential in order to maintain adequate diastolic filling between beats, in the face 
of an increase in heart rate that occurs upon sympathetic nerve stimulation (145). 
Finally, sympathetic signaling modulates the rapidly activating, delayed-rectifier, 
potassium channel in a highly complex manner, resulting in opposite effects on 
current amplitude (145).  
Sympathetic denervation by β-blockers exerts opposite effects on 
repolarization of cardiac myocytes. For example, administration of β-blockers 
such as atenolol and sotalol caused action potential duration (APD) prolongation 
(66, 103), while esmolol caused APD shortening by inhibiting L-type calcium 
current (40). Similarly, sympathetic denervation by stellate  ganglionectomy 
(dogs) or phenol (rabbits) resulted in prolongation of repolarization (139, 140) , 
while bilateral sympathetic ganglionegtomy resulted in shortening of APD in a 
study of rats (136). 
2.2.2 Autonomic Innervation of Ventricles 
Sympathetic stimulation improves synchrony of excitation and contraction 
(3). Stimulation of individual cardiac nerve induces highly localized and 
differential changes in automatic, conductile and contractile function (3). For 
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example, right stellate ganglionectomy in dogs resulted in larger prolongation of 
functional refractory period at the anterior surface of the heart than at the 
posterior surface, while additional left stellate ganglionectomy resulted in larger 
prolongation of functional refractory period at the posterior surface than at the 
anterior surface (139). In addition, a single sympathetic nerve modulates finer 
myocardial segment. For example, electrical excitation of distal ventrolateral 
cardiac nerve induces increased contraction of posterior papillary muscle without 
noticeable alteration in the anterior papillary muscle of the same ventricle (3); 
comparable stimulation of ventromedial cardiac nerve increases anterior papillary 
muscle contraction without affecting the posterior muscle (3). 
Distribution of sympathetic nerves in epicardium, endocardium and 
midmyocardium of animal heart has been reported (26). Percentage stained area 
of tyrosine hydroxylase- and neuropeptide Y-immunoreactive nerves 
(sympathetic nerves) are largest in epicardium, smaller in endocardium and 
smallest in midmyocardium (26).  
2.2.3 Cardiac Autonomic Dysfunction in Diabetes  
Direct measure of cardiac sympathetic innervation can be performed by 
MIBG-SPECT and HED-PET imaging (54, 63). The measures of cardiac 
autonomic neuropathy by MIBG-SPECT and HED-PET (122) have revealed 
inhomogeneous sympathetic innvervation of the left ventricle in diabetic patients 
(22, 56, 91, 92, 113-116). Low uptake of tracer has been observed in the 
posterior, inferior, or dorso-septal areas of the left ventricle in diabetic patients. 
The region with low uptake of MIBG extended to other areas in patients with 
autonomic neuropathy. A recent study, using MIBG-SPECT imaging, showed 
that in patients with innervation defects, 46% of the innervation defects were 
located at the inferior region, 18% were located at more than one region, 16% 
showed diffuse diminished uptake, 14% were located at the apex and 6% were 
located at the anterior region (115). Proximal hyperinnervation complicating distal 
denervation in diabetic patients with normal myocardial perfusion has also been 
reported (123).  
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2.2.4 Previous Simulation Studies 
The forward problem and inverse problem of electrocardiography have 
been the focus of simulation studies attempting to locate the site of abnormal 
electrical activity of the heart in patients with myocardial infarction (41), Wolff-
Parkinson-White syndrome (48), long-QT syndrome (68) and bundle branch 
block (2). The forward problem estimates the body surface potential from an 
equivalent source of cardiac electrical activity while the inverse problem 
approximates the electrical properties of the heart from measured body surface 
potential (53). The relationship between increases in QTc interval and the extent 
of diabetic autonomic neuropathy, diagnosed by clinical methods, implies that the 
change in ventricular repolarization of myocardium may be a result of alterations 
in cardiac innervation. To our knowledge, this study is the first to describe 
possible mechanisms of QTc interval prolongation in diabetics with autonomic 
neuropathy by using a priori changes in membrane potentials at the cellular level 
directly to predict changes in body surface potentials. This study aims to link the 
QT interval prolongation observed in diabetic patients with autonomic neuropathy 
to the patterns of regional cardiac sympathetic denervation. 
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2.3 Chapter Three: Methods 
2.3.1 Experimental Study 
2.3.1.1 Subjects 
The subjects of this part of study were the same as in Part 1, which 
consisted of 12 able-bodied subjects, 7 diabetics without neuropathy, 7 with mild 
neuropathy and 8 with severe neuropathy. 
2.3.1.2 Data acquisition 
Twelve-lead ECG was acquired from supine subjects breathing at15 
breaths/min. Data acquisition of 12-lead ECG lasted for approximately 5 min or 
until at least 256 heart beats were recorded for signal averaging.      
2.3.1.3 Signal Preprocessing 
Before performing QT interval measurement, ECG signals were 
processed to remove baseline wander (< 1Hz), power line noise (~60 Hz) and 
muscle noise for accurate characteristic wave detection (1). Baseline wander and 
power line noise were removed by two digital filters, a highpass and a lowpass 
filter, designed to meet American Heart Association (AHA) recommendations for 
minimizing distortion: amplitude response should be flat to within 6% (0.5 dB) 
over a range of 1.0-30 Hz; the 3 dB points should be less than or equal to 0.67 
Hz (6). A butterworth filter is known to have a flat response at pass band and was 
therefore applied in this study. The MATLAB command ‘buttord’ was used to 
determine the order and cutoff frequency with these specifications. A highpass 
filter with 3 dB point at 0.67 Hz, and 60 dB point at 0.025 Hz, required a minimum 
order of 3, rendering the response at 1 Hz to be -0.38 dB. A lowpass filter with 3 
dB point of 40 Hz, and 60 dB point of 250 Hz, required a minimum order of 4, 
rendering the response at 30 Hz to be -0.41dB. Then, filter coefficients were 
generated by using the MATLAB command ‘butter’, and signals were filtered 
forward and then backward to give a response with zero phase shift, by using the 
MATLAB command ‘filtfilt’.  
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After filtering, ECG waveforms of multiple beats were coherently averaged 
to remove muscle noise in the signal and improve signal-to-noise ratio (1, 76). 
Before averaging, the R peak of each beat was determined by setting a 
magnitude threshold manually, from which RR intervals (RRI) were calculated. 
Only beats having an RRI with the difference from the mean RRI less than 10%, 
were accepted for averaging (76). Segments which started 400 msec before the 
R peak and ended at the end of the P wave of the next beat (accepted beats) 
were aligned at the R peak, summed point by point, and then divided by the 
number of beats. QT interval was measured from the averaged waveform in each 
lead. 
2.3.1.4 QT Interval Measurement 
QT interval was measured by observing the signal and clicking in the 
graph of the signal at the Q wave onset and T wave end (Figure 2.1). The 
measurement was done without knowing the classification of subjects. The Q 
wave beginning was determined at the first deflection from baseline after the P 
wave. The T wave end was determined at the time when the signal went back to 
the TP baseline. If the T wave went asymptotically to the baseline, then the T 
wave end was determined as the intercept of the slope of the fastest decreasing 
segment of the T wave and the TP baseline. If a T wave was followed by a U 
wave, the T wave end was taken as the nadir between the T wave and the U 
wave. Merging of T wave with U/P wave, low T wave amplitude and various T 
wave morphologies have been reported to cause measurement error (82). If any 
of these features was present, the measurement was abandoned for that lead. 
Seventeen subjects had 1~3 leads abandoned. QT interval was not measured for 
one subject because of the presence of these features in most leads. QT interval 
was averaged from three measurements at different times. The heart rate 
corrected QT interval (QTc) was computed with Bazett’s equation  
𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑄𝑇 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 (𝑄𝑇𝑐) =  
𝑄𝑇 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙
√ 𝑅𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙
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Maximum and minimum QTc of all leads were determined from the 12 leads. 
Minimum QTc of inferior leads (leads II, III and aVF), septal leads (leads V1 and 
V2), anterior leads (leads V3 and V4) and lateral leads (leads I, aVL, V5 and V6) 
were also determined (94). 
Figure 2.1 Typical averaged ECG complexes and manual QT interval 
measurement. 
2.3.2 Simulation Study 
2.3.2.1  Structure of Ventricles 
The geometry of the ventricles was constructed by forming 90 cross-
sections along planes perpendicular to the base to apex axis. Each cross-section 
contained a ring with 9 concentric circles with different radiuses, constructing the 
transmural layers of left ventricle, and 3 concentric partial circles with different 
radiuses, constructing the transmural layers of right ventricle. This was done by 
the following steps:  
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1) Construct a 90mm*60mm*90mm cubic consisting of a rectangular grid of 
discrete points with 1mm distance between points.  
2) Determine the centers of the circles of left ventricle at all cross-sections, which 
was a vertically straight line consisting of points with the same x and y 
coordinates at all cross-sections.  
3) Determine the radiuses of the circles of the left ventricle of all cross-sections, 
which was determined by an ellipse equation representing the curved shape of 
the ventricular walls.  
4) Recruit elements in the cubic, one cross-section by one cross-section, and 
one transmural layer by one transmural layer, with every transmural layer 
determined by their distances to the center of the circles. An ID of the transmural 
layer was assigned to every element ranging from 1 to 9 (Figure 2.2).  
5) Determine the centers of partial circles of right ventricles as points along the 
right side of the septum. Because the centers of right ventricle formed a curve, 
the lateral wall of right ventricle was more curved than that of the left ventricle.  
6) Determine the radiuses of the partial circles of the right ventricle, one cross-
section by one cross-section, which decreased from base to apex, according to 
an ellipse equation.  
7) Recruit the elements in the cubic to form the right ventricle, one cross-section 
by one cross-section, and one transmural layer by one transmural layer, with 
every transmural layer determined by their distances to the center of the partial 
circles, which are equal to the radiuses. An ID of each transmural layer was 
assigned to every elements ranging from 1 to 3 (Figure 2.2). 
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Figure 2.2 Transmural layers of left and right ventricles, from endocardium 
to epicardium. 
8) In addition to the ID of transmural layers, the ID of endo-, mid- or epi- 
myocardium was also assigned (Figure 2.3).  
 
 
Figure 2.3 Determination of endocardium (orange), midmyocardium (green) 
and epicardium (blue). 
9) A region ID was also assigned to every element (Figure 2.4). The regions 
were divided according to the polar map of the left ventricle in MIBG-SPECT 
imaging (55): apical, distal/basal anterior, distal/basal inferior, distal/basal septal 
and distal/basal lateral regions.  
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Figure 2.4 Division of the regions of left ventricle (3D view, left; top view, 
right). 
 
These resulted in a three-dimensional array of 129,826 points 
representing the ventricles of the heart. The construction of the model and 
following simulations were performed in MATLAB. 
2.3.2.2 Normal Electrical Activity of Heart – Activation Sequence 
Production of Normal Activation. Clinical endocardial excitation map of 
human left ventricle showed that the site with the earliest excitation of the left 
ventricle was located in an area between the middle and anterior septum near 
the apex (personal communication with Dr. Morales). Therefore, at the left side of 
the septum, one point between middle and anterior area near the apex was 
assigned with the earliest activation time (Figure 2.5). In the right ventricle, two 
points at the free wall and the septum near the apex were assigned an activation 
time 5 msec later than that of the left ventricle, as indicated by the activation 
sequence of an isolated human heart (33). 
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Figure 2.5 Production of normal electrical activities of left and right 
ventricles (3D view, top; front view, bottom left; top view, bottom right). 
 
Electrical Excitation Propagations to Six Nearest Neighbors. When one 
element was activated, the excitation propagated to its six nearest neighbors at 
the next time step or in the next few time steps, according to the conduction 
velocity. With 1mm distance between elements and the largest conduction 
velocity of 4 m/s, the smallest time step was set to be 0.25 msec. The activation 
propagation to neighbors was delayed in regions with a slower conduction 
velocity. The transmural velocity ranged from 0.222 m/s to 0.45 m/s (33). The 
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slowest transmural velocity speed was at the septum, and the transmural velocity 
increased gradually from 0.25 m/s, at the apex, to 0.45 m/s, at the base of the 
free walls. This difference in velocity was adopted from the excitation isochrone 
of the isolated human heart, in which transmural velocity was slower in the area 
where excitation occurred earlier (33). Therefore, in this model, the transmural 
velocity described above was assigned to make the earlier excitation area have 
slower transmural velocity. Faster conduction velocities were assigned to 
endocardia to simulate the Purkinje network. As shown in Figure 2.6, the 
endocardia had a fast conduction velocity 4 m/s in a fan pattern, and other 
endocardia between the lines of the fan had conduction velocity of 2 m/s. This 
arrangement of conduction velocity between endocardial cells led the 
propagation of excitation from apex to base.  
 
Figure 2.6 Propagation speed of electrical activation to six neighbors (3D 
view, left; top view, right). 
The resultant activation sequence is shown at a series of horizontal cross-
sections, a middle-front cross-section (Figure 2.7), endocardial layers and 
epicardial layers (Figure 2.8). 
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Figure 2.7 Activation sequence at horizontal cross-sections (left) and 
middle frontal cross-section (right). 
 
 
Figure 2.8 Activation map of endocardium (left) and epicardium (right). 
2.3.2.3 Normal Electrical Activity of Heart – Repolarization 
Distribution of Action Potential Duration (APD). The length of APD was 
different in the three types of myocardium: midmyocardium longest, endocardium 
shorter and epicardium shortest (138). The APDs increased gradually from 
endocardium to midmyocardium, and decreased sharply from subepicardium to 
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epicardium transmurally (138). In addition, APDs at the apex were slightly longer 
than those at the base (118). In the septum, APDs progressively lengthened from 
right ventricular to left ventricular endocardium (89). In this model, the normal 
APD distribution had a transmural gradient and an apex-to-base gradient. At the 
apex, APDs of the elements from epicardium layer to endocardium layer at the 
free wall of the left ventricle were 216, 222, 246, 252, 258, 264, 270, 264, 258 
msec, at the septum were 224, 227, 230, 233, 236, 239, 242, 245, 248 msec, 
and at the free wall of right ventricle were 206, 230 and 224 msec. The APD 
decreased gradually from apex to base, so that APDs were 10 msec shorter at 
the base than those at the apex. The distribution of APD is shown in Figure 2.9. 
 
Figure 2.9 Distribution of action potential durations (3D view, top; middle 
horizontal cross section, bottom left; middle front cross section, bottom 
right). 
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Cellular Action Potential Model. The intracellular action potential model 
consisted of a step change from resting potential -90 mV to 10 mV simulating 
depolarization, followed by six linear lines changing from 10 mV to -90 mV 
simulating repolarization. Similar to a previous study (86), the differences of APD 
were accomplished by proportionally changing the lengths of the first two lines of 
repolarization (Figure 2.10). In the abnormal model, the prolongation or 
shortening of APD was accomplished by proportionally prolonging or shortening 
the lengths of the first two lines of repolarization. 
 
Figure 2.10 Model of intracellular action potential with different durations. 
 
2.3.2.4 Heart-Torso Model 
Position of Heart in Torso. The torso was modeled as an homogeneous 
volume conductor. The torso has a cylinder shape with maximum length 300 mm 
from left to right, maximum length 200 mm from front to back and 350 mm from 
top to bottom (Figure 2.11). The heart model, located inside the torso model, was 
surrounded by the point elements on the torso surface. The position of the heart 
inside the torso was determined by first setting the center of the heart model the 
same with that of the torso model except 50 mm higher than the torso model. 
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This resulted in the anterior side of both ventricles facing the front side of the 
torso model. Then the heart model was rotated by 45 deg along the longitudinal 
axis of the torso and then 45 deg along the mediolateral axis of the heart model. 
After the rotations, the heart model was displaced to the left side of the torso by 
90 mm and the front side by 45 mm. This resulted in the heart model being closer 
to the left and front side of the torso model and the apex pointing towards the left 
down side. The locations of the electrodes of 12-lead ECG were determined on 
the body surface according to the standard placement. 
 
 
Figure 2.11 Views of heart inside torso, heart rotation and positions of 
electrodes (3D view, top left; lateral view from left, top right; top view, 
bottom left; front view, bottom right). 
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Body surface potential: solution of forward problem. The computation of 
surface potentials was similar to that of Miller et al. (86) except that this study 
calculated the current dipole at each point of the heart model, instead of dividing 
the heart model into 23 regions. Considering a three dimensionally distributed 
myocardia network, if the gradient of the intracellular potential exists, there will be 
a current flow from high intracellular potential to low intracellular potential as 
𝐽?̅? = −𝜎𝑖∇∅𝑖 
where 𝐽?̅? is intracellular current density,  𝜎𝑖 is the effective conductance of 
intracellular network (set to equal to 1 in the model) and ∅𝑖 is the intracellular 
potential.  
In this model, the individual myocardial segments were discrete points in a 
rectangular grid, therefore the gradient function at one point can be approximated 
as the potential differences of it six neighbors as 
∆∅𝑙,𝑚,𝑛 =
∅𝑙+1,𝑚,𝑛 − ∅𝑙−1,𝑚,𝑛
2∆𝑙
𝑙 ̅+
∅𝑙,𝑚+1,𝑛 − ∅𝑙,𝑚−1,𝑛
2∆𝑚
𝑚� +
∅𝑙,𝑚,𝑛+1 − ∅𝑙,𝑚,𝑛−1
2∆𝑛
𝑛� 
where ∅𝑙,𝑚,𝑛 is the intracellular potential at point 𝑙,𝑚,𝑛 in the three dimensional 
grid, ∆𝑙 is the distance between two points and 𝑙 ̅is the unit vector along the 𝑙 axis. 
The directions of the unit vectors are shown in Figure 2.12. The unit vectors were 
fixed three-element arrays acquired by scaling the length of the three vectors. 
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Figure 2.12 Directions of unit vectors of the heart coordinates along the 
dimension of the cell grid in the directions of the l, m and n axes (green, 
red and purple lines). 
The volume integral of the current density 𝐽?̅? at the small space around a 
point can be approximated as following and is equivalent to a current dipole (105) 
𝑃�𝑙,𝑚,𝑛 = −𝜎𝑖(∇∅𝑙,𝑚,𝑛)𝑑𝑙𝑑𝑚𝑑𝑛 
The simulation sources are thus a set of 129,826 time-varying current dipoles. 
The electrical field of one observation point on the body surface (xp, yp, zp) can 
be calculated as follows 
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where 𝑢�𝑥,𝑦,𝑧,𝑥𝑝,𝑦𝑝,𝑧𝑝 is a three-element array, representing the unit vector pointing 
from an element at (x, y, z) of the heart model towards an electrode on the body 
surface at (xp, yp, zp). r is the distance between the element at (x, y, z) of the 
heart model and the electrode on the body surface at (xp, yp, zp). ε0 is the 
permittivity of free space. In the model, the permittivity was set to be 1 according 
to the assumption that the torso was an homogenous conductor. 
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Twelve-lead ECG is calculated from the 9 body surface potentials at the 
locations of the electrodes RA, LA, LL, V1, V2, V3, V4, V5 and V6 as the 
following: 
1) limb leads 
LALLIII
RALLII
RALAI
−=
−=
−=
 
2) augmented limb leads 
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2
1
)(
2
1
)(
2
1
LARALLaVF
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+−=
 
3) precordial leads 
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where VW is the Wilson's central terminal used as the negative electrode for the 
precordial leads. 
QT interval measurement of modeled ECG. The T wave end of modeled 
ECG was determined by using a voltage threshold method. The peak of the T 
wave was identified at the time when the ECG arrived at its maximum absolute 
value after the QRS complex. The end of the T wave was identified when the 
absolute voltage of the T wave decreased to ten percent of the voltage of the T 
peak (Figure 2.13). The QT interval was computed as the time difference 
between first activation and the T wave end. 
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Figure 2.13 Twelve-lead ECG generated from normal model and the 
detection of the T peak and the T wave end. 
Regional dipoles and 12-lead ECG. The activities of the heart model with 
all parts integrated are shown in the movie ‘Heart Model and ECG.wmv’. Dipoles 
were estimated at every cell element as a source of the electrical field of the 
extracellular space, which were proportional to the differences of the intracullular 
potentials of its six neighbors. In order to visualize the contribution of the dipoles 
of all regions, the dipoles of one region were averaged and ploted as a green 
quiver located at the average of the coordinates of the cell elements in that 
region. The direction of the quiver corresponds to the direction pointing from the 
negative charge to the positive charge of the dipole. In order to visualize the 
major force of the heart model, which is reflective of the general morphology of 
the ECG, the average dipole of all cell elements of the heart was plotted as a red 
quiver located at the average of the coordinates of all cell elements. The 
intracellular potentials and dipoles changed with time during the processes of 
depolarization and repolarization of the heart, generating the QRS complex and 
T wave in ECG (see movie). 
2.3.2.5 Diabetes Effects on Normal Heart 
Prolongation and Shortening of Action Potential. In two previous animal 
studies, cardiac sympathetic denervation by stellate ganglionectomy or phenol 
resulted in prolongation of the functional refractory period (139) or activation-
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recovery interval (140), while in another animal study, cardiac sympathetic 
denervation by bilateral sympathetic ganglionegtomy resulted in shortening of the 
APD (136). In this study, both prolongation and shortening of the action potential 
were simulated. 
Transmural differences of APD changes. It has been shown that the 
stained area of tyrosin hydroxylase- and NPY- immunoreactive nerves 
(sympathetic nerves) was largest in epicardium followed by endocardium, and 
was smallest in midmyocardium in pig heart (26). The ratio of the stained areas 
was approximately 5:3:1 in epicardium, endocardium and midmyocardium, 
respectively (26). In this study, APD changes applied in epicardium, endocardium 
and midmyocardium in the heart model were set accordingly with this ratio. 
Regions in the heart model being affected. Four patterns of abnormal 
cardiac sympathetic innervation have been reported in studies of diabetic cardiac 
autonomic neuropathy, shown by MIBG-SPECT or HED-PET images: 1) low 
tracer uptake in one region, 2) low tracer uptake in more than one region, 3) 
reduced uptake in the whole heart, and 4) denervation in distal regions 
complicated by hyperinnervation in basal regions. In the heart model, regions of 
the left ventricular walls and septum were divided according to the polar map, 
which was used previously in a MIBG-SPECT study (55). Hyperinnervation was 
simulated by applying the opposite APD changes of denervation. Figure 2.14 and 
Figure 2.15 show examples of prolonging and shortening of APD at one region, 
the basal anterior region. 
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Figure 2.14 Example of simulation of possible effects of diabetic 
neuropathy to the heart: prolongation of APD at basal anterior region. 
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Figure 2.15 Example of simulation of possible effects of diabetic 
neuropathy to the heart: shortening of APD at basal anterior region. 
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Matching procedure. In order to link clinically observed QT interval 
changes, to cardiac sympathetic denervation or hyperinnervation seen in cardiac 
imaging studies, the following procedure was followed:  
1) In experimental ECG, QT interval changes in diabetic patients with neuropathy, 
compared to those of able-bodied subjects were characterized.  
2) In the model, simulations of abnormal heart with different patterns of cardiac 
sympathetic denervation or hyperinnervation were performed.  
3) Within the results of simulation, the pattern that generated 12-lead ECG and 
QT intervals which best matched the characteristics of experimental QT intervals 
of diabetics with neuropathy was chosen as an inverse solution. 
4) In the model, abnormal patterns were further modified to determine whether 
the characteristics of experimental QT intervals could be better matched. 
2.4 Chapter Four: Results 
2.4.1 Experimental ECG 
Group mean RR intervals of supine able-bodied subjects, diabetics 
without neuropathy, diabetics with mild neuropathy and diabetics with severe 
neuropathy are shown in Figure 2.16. RR interval tended to be different among 
groups (p=0.0829, ANOVA).  
 
Figure 2.16 Five-minute, resting, average ± SEM RR interval of able-bodied 
subjects (AB), diabetics without neuropathy (D0), diabetics with mild 
neuropathy (D1) and diabetics with severe neuropathy (D2). 
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Group mean QT intervals and heart rate-corrected QT interval (QTc) of 12 
leads are shown in Figure 2.17. QT intervals of able-bodied subjects did not differ 
from those of diabetics with severe neuropathy. QTc of able-bodied subjects 
tended to be shorter than diabetics with severe neuropathy (p=0.051 for lead aVL, 
p=0.104 for lead I, using two-tail t test between able-bodied subjects and 
diabetics with severe neuropathy). QTc intervals of diabetics without neuropathy 
tended to be the longest in the four groups. 
 
 
Figure 2.17 Average ± SEM QT interval (top) and heart rate-corrected QT 
interval (QTc, bottom) of 12-lead ECG of four groups. 
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Maximum and minimum QTc of all leads measured over supine control 
period are shown in Figure 2.18. Maximum QTc was not different between able-
bodied subjects and diabetics with severe neuropathy. Minimum QTc was not 
different between able-bodied subjects and diabetics with severe neuropathy, but 
demonstrated a tendency to be different. 
 
Figure 2.18 Individual maximum QTc (left) and minimum QTc (right) of all 
leads in the four groups. 
  
Minimum QTc of septal leads, anterior leads, lateral leads and inferior 
leads for all subjects are shown in Figure 2.19. Minimum QTc of lateral leads 
tended to be different between able-bodied subjects and diabetics with severe 
neuropathy (p = 0.095, two-tail t test between able-bodied subjects and diabetics 
with severe neuropathy). 
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Figure 2.19 Individual minimum QTc of septal leads (top left), anterior leads 
(top right), lateral leads (bottom left) and inferior leads (bottom right) of the 
four groups. 
 
Two characteristics were identified in QTc interval to be matched by the 
model. First, diabetics with severe neuropathy tended to have longer QTc interval 
in all leads than did able-bodied subjects. Second, minimum QTc interval from 
lateral leads demonstrated greater group difference between able-bodied 
subjects and diabetics with severe neuropathy when compared to other leads. In 
addition, a third characteristic of ECG, morphology, needed to be matched. 
Specifically, the T waves of lateral leads V5 and V6 should be positive which was 
observed in the ECG of all subjects. 
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2.4.2 Modeled ECG – Normal Model 
QT intervals of 12-lead ECG from the model of the normal heart are 
shown in Figure 2.20. Compared to the QTc interval of 12-lead ECG from able-
bodied subjects, there was a similar dip at lead V2. The lack of a dip at aVL in 
the model, compared to the able-bodied subjects, did not appear to be an 
important factor in model function, perhaps due to the anatomy of the model vs. 
real heart. In the subsequent simulation of abnormal heart, changes from normal 
QT intervals were computed. 
 
Figure 2.20 QT interval of 12 leads generated from normal model. 
 
2.4.3 Modeled ECG - Diabetic Effect on Normal Model 
Determination of the amount of APD changes in simulation. In order to 
determine the amount of APD changes, the effects of changing APD on 12-lead 
ECG and QT interval were assessed, by prolonging and shortening APD to 
different extent at one region (Figure 2.21, Figure 2.22). The shape of ECG 
showed that shortening APD at one region, for example, in the distal inferior 
region, primarily modified the ST segment and the ascending part of the T wave 
(blue lines in Figure 2.21). Conversely, prolonging APD in the distal inferior 
region primarily modifed the descending part of the T wave (red lines in Figure 
2.21). Greater APD prolongation generated greater changes in QT interval 
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(Figure 2.22). In subsequent simulations, a 60 msec change in epicardial APD, 
36 msec endocardial and 12 msec midmyocardial generated changes of QT 
interval by the desired amount of  20 msec, as observed in the QTc interval of 
lateral leads. Some exceptions occurred; 1) at the septum, 36 msec change was 
applied at both sides of the endocardium; 2) to simulate diffuse reduction of 
innervation, 20 msec change in APD at the epicardium, 12 msec at the 
endocardium and 4 msec at the midmyocardium were applied to the whole 
septem and left ventricular walls, in order to correspond to the definition of diffuse 
uptake of MIBG observed in a previous study that reported reduced global heart-
to-mediastinum ratio without obvious regional defect in SPECT polar map (115). 
Although shortening APD in the distal inferior region did not produced QT interval 
prolongation in most leads, as did prolonging APD (Figure 2.22), it did prolong 
QT interval in several leads. Therefore, both prolonged and shortened APD were 
applied, respectively. 
 
Figure 2.21 Twelve-lead ECG of normal model and abnormal models by 
prolonging or shortening APD to different extent in the distal inferior region. 
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Figure 2.22 QT interval of 12 leads of normal model and abnormal models 
by prolonging or shortening APD in the distal inferior region, when 
applying different magnitudes of APD changes. 
 
QT interval from simulation of regional abnormalities of cardiac 
sympathetic innervation. Action potential durations were prolonged or shortened 
by 60 msec at the epicardium, 36 msec at the endocardium and 12 msec at the 
midmyocardium in the following single regions respectively: distal inferior, basal 
inferior, distal lateral, basal lateral, distal anterior, basal anterior, distal septal, 
basal septal regions and apex. QT intervals were computed in every trial. QT 
interval changes due to prolonging APD at these regions are shown in Figure 
2.23. QT interval changes due to shortening APD at these regions are shown in 
Figure 2.24. The patterns that prolonged APD in the distal lateral or basal septal 
regions were selected because these modifications generated increases in QT 
intervals of all leads. 
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Figure 2.23 Delta of QT interval of 12 leads from normal model, resulting 
from prolonging APD in one region. 
 
Figure 2.24 Delta of QT interval of 12 leads from normal model, resulting 
from shortening APD in one region. 
 
Simulations of hyperinnervation in the basal region complicated by the 
loss of innervation in the distal region were simulated by prolonging APD in the 
distal region and shortening APD in basal region. Results of QT interval changes 
due to this simulation are shown in Figure 2.25. QT interval changes due to 
shortening APD in the distal region and prolonging APD in the basal region are 
shown in Figure 2.26. The pattern of prolonging APD in the distal, and shortening 
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APD in the basal septal region was selected because this modification generated 
increases in QT interval of all leads. 
 
 
Figure 2.25 Delta of QT interval of 12 leads from normal model, resulting 
from prolonging APD in  distal, and shortening APD in basal regions. 
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Figure 2.26 Delta of QT interval of 12 leads from normal model, resulting 
from shortening APD in distal,  and prolonging APD in basal regions. 
 
Finally, because the distal inferior region has frequenty been reported to 
be the first region affected, and an extension from this region has been observed 
in patients with more severe neuropathy, simulations of loss of innervation in two 
regions, extending from distal inferior to basal inferior, distal septal,distal lateral 
or apical regions were performed. In addition, diffuse denervation was also 
simulated by changing APD in the whole left ventricle. QT interval changes due 
to prolonging APD in these regions are shown in Figure 2.27. QT interval 
changes due to shortening APD in these regions are shown in Figure 2.28. The 
pattern that prolonged APD at distal inferior and distal lateral regions was 
selected because this pattern generated increases in QT interval of all leads. 
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Figure 2.27 Delta of QT interval of 12 leads from normal model, resulting 
from prolonging APD in two regions or prolonging APD diffusely. 
 
 
Figure 2.28 . Delta of QT interval of 12 leads from normal model, resulting 
from shortening APD in two regions or shortening APD diffusely. 
 
Twelve-lead ECG of selected patterns were then plotted against normal 
12-lead ECG to compare the morpholoy of ECG. Figure 2.29 shows ECGs from 
the simulation that prolonged APD in the distal lateral region. Prolonging APD in 
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this region resulted in changes in the morphology of ECGs and generated an 
inverted T wave in leads V5 and V6. 
 
Figure 2.29 Twelve-lead ECG of the simulation that prolonged APD in the 
distal lateral region, plotted against normal ECG. 
Figure 2.30 shows ECGs of the simulation that prolonged APD in the 
basal septal region. Prolonging APD in the basal septal region preserved the 
morphology of ECG. 
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Figure 2.30 Twelve-lead ECG of the simulation that prolonged APD in the 
basal septal region, plotted against normal ECG. 
 
Figure 2.31 shows ECGs from the simulation that prolonged APD in the 
distal lateral region and shortened APD in the basal lateral region. Prolonging 
APD in the distal lateral region with shortening APD in the basal lateral region 
resulted in changes in the morphology of ECG and generated inverted T wave in 
leads V5 and V6. 
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Figure 2.31 Twelve-lead ECG of the simulation that prolonged APD in the 
distal lateral region and shortened APD in the basal lateral region, plotted 
against normal ECG. 
Figure 2.32 shows ECGs of the simulation that prolonged APD at distal 
inferior and distal lateral regions. Prolonging APD at distal inferior and distal 
lateral regions resulted in changes in the morphology of ECG and generated 
inverted T wave in leads V5 and V6. 
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Figure 2.32 Twelve-lead ECG of the simulation that prolonged APD in the 
distal inferior and distal lateral regions, plotted against normal ECG. 
Determination of the pattern with the best match. From the comparison of  
the change in QT interval and morphology of ECGs, the pattern of prolonging 
APD in the basal septal region yielded the best match to experimental data. 
Specifically, 1) QT interval increased in all leads, and 2) the morphology of ECG 
was preserved. In addition, the minimum QT interval of lateral leads increased by 
15 msec, 2 msec longer than from all leads.  
Further modifcations. Because in diabetic patients with more severe 
autonomic neuropathy, the loss of tracer activity in the same region is more 
pronounced and the affected region extends to other regions (91, 93, 113, 123), 
the simulations of longer prolongation of APD (60 msec at endocardium and 20 
msec at midmyocardim) in the basal septal region, and prolonging APD in 
regions near the basal septal region were performed, respectively. QT interval 
changes due to prolonging APD in two regions (basal septal and distal septal 
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regions, basal septal and basal inferior regions, basal septal and basal anterior 
regions) are shown in Figure 2.33. Compared to changing APD in a single basal 
septal region, extension of regions did not alter QT intervals of lateral leads 
(leads I, aVL, V5 and V6), but other leads. Prolonging APD in the single basal 
septal region was chosen to be the pattern that best matched observed results. 
 
Figure 2.33 Delta of QT interval of 12 leads from the normal model, 
resulting from prolonging APD in two regions, extended from the basal 
septal region. 
 
QT interval changes due to longer prolongation of APD in the basal septal 
region are shown in Figure 2.34. Additional prolongation of APD generated larger 
changes in QT interval in most leads. 
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Figure 2.34 Delta of QT interval of 12 leads from thenormal model, resulting 
from prolonging APD with larger prolongation in the basal septal region. 
 
Intracellular potential and dipoles in normal model and abnormal model. In 
order to verify the changes in the forward solution, the cardiac source of modified 
model with the chosen pattern was plotted against that of the normal  model. The 
intracellular potentials of the nine transmural layers (from epicardium to 
endocardium) of the left ventricle of the normal model were shown at the top left 
side of Figure 2.35, Figure 2.36 and Figure 2.37, for different times. In order to 
show the septum, the right ventricle is not included. At the end of the QRS of the 
normal ECG, all cell elements were activated and intracellular potentials were 
homogeneous (Figure 2.35). At the peak of the T wave, intracellur potentials 
were inhomogenous, representing different stages of repolarization (Figure 2.36). 
At the end of the T wave, all cell elements were back to resting potentials (Figure 
2.37). The intracellular potentials of the left ventricle of the abnormal model, 
obtained by prolonging APD in the basal septal region, are shown at the top right 
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side of Figure 2.35, Figure 2.36 and Figure 2.37, for different times. At the time of 
the end of the QRS of the normal ECG (Figure 2.35), all cell elements were 
activated, similar to those of the normal model. At the peak of the T wave (Figure 
2.36), repolarizations were more heterogeneous, due to higher potentials in the 
basal septal region (red and orange areas). Unlike the normal model, the cell 
elements in the basal septal region were still repolarizing at the end of the T 
wave (Figure 2.36). 
Dipoles and ECG of lateral leads of the normal heart model are also 
shown at the bottom of Figure 2.35, Figure 2.36 and Figure 2.37 for different 
times. Dipoles were estimated at every cell element as a source of the electrical 
field of the extracellular space, and were proportional to the differences of the 
intracullular potentials of its six neighbors. Similar to the dipoles shown in the 
movie ‘Heart Model and ECG’, the dipoles of one region were averaged and 
plotted as a green quiver located at the average of the coordinates of the cell 
elements in that region. The average dipole of all cell elements of the heart was 
plotted as a red quiver located at the average of the coordinates of all cell 
elements. The time at which these plots were made was marked on the ECG of 
the four lateral leads.  
At the end of QRS, in the normal heart model, the dipoles were small in 
amplitude and almost invisible (Figure 2.35, bottom left). It was similar in the 
abnormal model (Figure 2.35, bottom right).  
In the normal heart model, at the peak of the T wave, the major force of 
the heart model, reflected by the red quiver, pointed toward the lateral wall of left 
ventricle, generating positive T waves in lateral leads (Figure 2.36, bottom left). 
In the abnormal model, although the amplitude of the red quiver was larger, the 
direction was similar to that of the normal model, generating a more positive T 
wave (Figure 2.36, bottom right). 
At the end of the T wave, in the normal heart model, the dipoles again 
were small in amplitude and almost invisible (Figure 2.37, bottom left). The 
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voltages of normal ECGs were close to zero. In the abnormal model, the major 
force was larger than that of the normal model, due to the repolarizing cell 
elements at the basal  septal region (Figure 2.37, bottom right). The voltages of 
the abmormal ECGs were greater than zero. 
   
 
Figure 2.35 Intracellular potentials of nine transmural layers (from 
epicardium to endocardium), dipoles and the ECGs of lateral leads of the 
normal model (a, b, c, left) and the abnormal model, obtained by prolonging 
APD in the basal septal region (d, e, f, right) at the end of the QRS of 
normal ECG. 
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Figure 2.36 Intracellular potentials of nine transmural layers (from 
epicardium to endocardium), dipoles and the ECGs of lateral leads of the 
normal model (a, b, c left) and the abnormal model, obtained by prolonging 
APD in the basal septal region (d, e, f, right) at the peak of the T wave of 
normal ECG. 
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Figure 2.37 Intracellular potentials of nine transmural layers (from 
epicardium to endocardium), dipoles and the ECGs of lateral leads of the 
normal model (a, b, c left) and the abnormal model, obtained by prolonging 
APD in the basal septal region (d, e, f, right) at the end of the T wave of 
normal ECG. 
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2.5 Chapter Five: Discussion 
2.5.1 QT Interval Changes in Diabetic Patients with Autonomic 
Neuropathy. 
In this study, diabetic patients with severe neuropathy tended to have 
longer QTc intervals in lateral leads of 12-lead ECG, compared to those of able-
bodied subjects.  
It has been reported that diabetic patients with cardiovascular autonomic 
neuropathy, diagnosed by two abnormal results in cardiovascular reflex tests, 
had longer QTc interval than the control group (51, 83, 125). The association 
between QTc interval and the severity of autonomic neuropathy has also been 
reported (69, 83, 100). However, Gonin et al reported that 57% of the patients 
with cardiovascular autonomic neuropathy had a normal QTc interval (51). In 
those studies, the numbers of subjects were greater than that in our study, with 
the number of diabetic patients ranging from 73 to 266 patients. In addition, QTc 
interval was measured in one ECG lead in those studies. In contrast, in the 
present study, QTc intervals were also compared in regional leads recorded in 
the 12-lead ECG. This resulted in a more significant group difference in the 
minimum QTc interval of lateral leads when comparing diabetic patients with 
severe neuropathy to able-bodied subjects. Therefore, minimum QTc interval of 
lateral leads in 12-lead ECG may be more diagnostic that that of a single lead. 
Veglio et al reported that, in 3,250 insulin-dependent diabetic patients, 
prolonged QTc interval, measured on V5 lead of resting ECG, was more 
prevalent in female subjects, resulting in longer QTc in female, than in male, 
subjects (126). However, in the same study, the relation between QTc 
prolongation and autonomic neuropathy was not observed among females 
although it was observed among males. In our study, diabetes without 
neuropathy were dominated by female subjects (5 of 6 subjects were female). 
Therefore, the tendency for diabetics without neuropathy to have longer QTc 
interval than diabetics with neuropathy may be due to this gender difference 
(Figure 2.38). 
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Figure 2.38 Gender differences in QTc interval of lead V5 for able-bodied 
subjects (AB), diabetics without neuropathy (D0), diabetics with mild 
neuropathy (D1) and diabetics with severe neuropathy (D2). 
 
Conversely to prolongation of QTc interval, Ong et al reported a higher 
heart rate and shorter QTc interval in diabetic patients with autonomic 
neuropathy, diagnosed by reduced heart rate variability (98). However, different 
from our study, they recorded a much longer data record, one that lasted for 24 
hours.  
2.5.2 Regional Sympathetic Denervation to Left Ventricle in Diabetic 
Patients 
In studies of MIBG-SPECG or HED-PET images, which reveal 
sympathetic innervation to the left ventricle, diabetic patients without or with mild 
autonomic neuropathy demonstrate low uptake of tracer in the posterior wall (112, 
113), posterior-inferior wall  (91), inferior wall (56, 93), distal inferior wall  (123) 
and to a less extend, septal wall (114).  In diabetic patients with autonomic 
neuropathy, the defects in these regions were more pronounced and extended to 
other areas (91, 93, 113, 123). It has also been reported that reduced uptake of 
tracer was observed in anterior, lateral and apical regions (75, 115). In addition, 
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Claus et al reported a lack of tracer activity in dorso-septal region in diabetic 
patients, within whom 79% had somatic polyneuropathy (22). The finding of a 
defect in the dorso-septal region agreed with the simulations of the present study. 
The similarity between the defect region in the study of Claus et al and this study 
may be due to a similar stage of neuropathy in both studies of diabetic patients 
with polyneuropathy.  
2.5.3 Mechanisms of QT Interval Prolongation in Diabetic Neuropathy 
This simulation study suggested that different patterns of regional 
prolongation of APD in the left ventricle caused changes in QT intervals of 12-
lead ECG. It has been reported that regional defects in MIBG uptake was not 
correlated with QTc interval in diabetic patients (22, 112-114). However, in those 
studies, ECG was recorded in one lead. In fact, in the current simulation study, 
there were relatively smaller increases or even decreases in QT interval of lead II 
when prolonging APD. These results were seen in many patterns (for example, 1) 
those involving  distal inferior, basal inferior, distal anterior, basal anterior, or 
basal lateral regions, 2) with complications of hyperinnervation in inferior, anterior 
or septal regions, and 3) in two regions involving distal inferior, basal inferior, 
distal anterior and distal septal regions). Therefore, QTc interval of lead II may 
not be reflective of most patterns of regional denervation. Another possibility is 
that QTc interval of lead II is reflective of a more severe autonomic neuropathy, 
since QT interval was correlated with abnormal results in cardiovascular reflex 
tests, which is known to represent a more severe neuropathy (49). In this 
simulation study, increases in APD prolongation led to increases in QT interval 
prolongation of lead II (Figure 2.34), although extension of affected area did not 
have an effect on lead II ECG (Figure 2.33). 
2.5.4  Limitations 
Movement of the heart during contraction and relaxation was not 
considered in this model, which may influence the results of the morphology of 
the modeled ECG. In addition, the lack of effects of muscle orientation on the 
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propagation of excitation, the simplicity of the structure of the ventricles, and the 
assumption of an homogeneous conductor in the torso may also explain 
differences in the detail of the morphology of the ECG and the QT interval pattern 
of 12 leads, between the model and able-bodied subjects. In addition, the lack of 
direct comparison of simulation results with individual cardiac denervation pattern 
from cardiac images limits the interpretation of results. However, this model 
demonstrates the feasibility of using forward and inverse solutions to detect 
cardiac sympathetic denervation. 
  
100 
 
2.6 Chapter Six: Conclusions 
Diabetic patients with severe neuropathy tended to have longer QTc 
intervals in 12-lead ECG. The minimum QTc interval of lateral leads was more 
diagnostic than that from other leads. The change of QTc interval in diabetic 
patients with severe neuropathy compared to able-bodied subject may be due to 
a mechanism involving prolongation of APD at the basal septal region, due to 
cardiac sympathetic denervation. 
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2.7 Chapter Seven: Future Work 
Validation studies need to be performed by collecting MIBG-SPECT images 
and QT intervals in 12-lead ECG in diabetic patients. Results from these data 
sets would be used to verify the model. In addition, the inverse solution from 
body surface potential acquired from more electrodes could provide the potential 
to locate cardiac sympathetic denervation, and thus provide a time efficient and 
cost effective method to detect cardiac denervation in diabetic patients. Finally, 
refining the model by adding complexity (for example, inhomogeneity of the torso 
or orientation of muscle fibers) may improve the similarity between the model and 
a real heart.  
102 
 
REFERENCES 
1. Comprehensive electrocardiology. New York: Springer, 2010. 
2. Aoki M, Okamoto Y, Musha T, and Harumi K. Three-dimensional 
simulation of the ventricular depolarization and repolarization processes and 
body surface potentials: normal heart and bundle branch block. IEEE Trans 
Biomed Eng 34: 454-462, 1987. 
3. Armour JA, and Ardell JL. Neurocardiology. New York: Oxford University 
Press, 1994, p. xi, 443 p. 
4. Armstrong RG, Seely AJ, Kilby D, Journeay WS, and Kenny GP. 
Cardiovascular and Thermal Responses to Repeated Head-Up Tilts Following 
Exercise-Induced Heat Stress. Aviat Space Environ Med 81: 646-653, 2010. 
5. Aslan SC, Randall DC, Donohue KD, Knapp CF, Patwardhan AR, 
McDowell SM, Taylor RF, and Evans JM. Blood pressure regulation in neurally 
intact human vs. acutely injured paraplegic and tetraplegic patients during 
passive tilt. Am J Physiol Regul Integr Comp Physiol 292: R1146-1157, 2007. 
6. Bailey JJ, Berson AS, Garson A, Jr., Horan LG, Macfarlane PW, Mortara 
DW, and Zywietz C. Recommendations for standardization and specifications in 
automated electrocardiography: bandwidth and digital signal processing. A report 
for health professionals by an ad hoc writing group of the Committee on 
Electrocardiography and Cardiac Electrophysiology of the Council on Clinical 
Cardiology, American Heart Association. Circulation 81: 730-739, 1990. 
7. Barnett SR, Morin RJ, Kiely DK, Gagnon M, Azhar G, Knight EL, Nelson 
JC, and Lipsitz LA. Effects of age and gender on autonomic control of blood 
pressure dynamics. Hypertension 33: 1195-1200, 1999. 
8. Bernardi L, Hayoz D, Wenzel R, Passino C, Calciati A, Weber R, and Noll 
G. Synchronous and baroceptor-sensitive oscillations in skin microcirculation: 
evidence for central autonomic control. American Journal of Physiology - Heart 
and Circulatory Physiology 273: H1867-H1878, 1997. 
9. Bernardi L, Radaelli A, Solda PL, Coats AJ, Reeder M, Calciati A, Garrard 
CS, and Sleight P. Autonomic control of skin microvessels: assessment by power 
103 
 
spectrum of photoplethysmographic waves. Clinical science (London, England : 
1979) 90: 345-355, 1996. 
10. Bernardi L, Rossi M, Fratino P, Finardi G, Mevio E, and Orlandi C. 
Relationship between phasic changes in human skin blood flow and autonomic 
tone. Microvascular Research 37: 16-27, 1989. 
11. Bernardi L, Rossi M, Leuzzi S, Mevio E, Fornasari G, Calciati A, Orlandi C, 
and Fratino P. Reduction of 0.1 Hz microcirculatory fluctuations as evidence of 
sympathetic dysfunction in insulin-dependent diabetes. Cardiovascular Research 
34: 185-191, 1997. 
12. Bertinieri G, di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, and Mancia 
G. A new approach to analysis of the arterial baroreflex. J Hypertens Suppl 3: 
S79-81, 1985. 
13. BOURGEOIS MJ, GILBERT BK, DONALD DE, and WOOD EH. 
Characteristics of Aortic Diastolic Pressure Decay with Application to the 
Continuous Monitoring of Changes in Peripheral Vascular Resistance. Circulation 
Research 35: 56-66, 1974. 
14. Brown DR, Brown LV, Patwardhan A, and Randall DC. Sympathetic 
activity and blood pressure are tightly coupled at 0.4 Hz in conscious rats. Am J 
Physiol 267: R1378-1384, 1994. 
15. Brown DR, Cassis LA, Silcox DL, Brown LV, and Randall DC. Empirical 
and theoretical analysis of the extremely low frequency arterial blood pressure 
power spectrum in unanesthetized rat. American Journal of Physiology - Heart 
and Circulatory Physiology 291: H2816-H2824, 2006. 
16. Butler GC, Yamamoto Y, Xing HC, Northey DR, and Hughson RL. Heart 
rate variability and fractal dimension during orthostatic challenges. J Appl Physiol 
75: 2602-2612, 1993. 
17. Cardoso CR, Salles GF, and Deccache W. Prognostic value of QT interval 
parameters in type 2 diabetes mellitus: results of a long-term follow-up 
prospective study. J Diabetes Complications 17: 169-178, 2003. 
18. Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, 
Parma G, Lissoni A, Fei F, Cundari S, and Zanna C. Grading of chemotherapy-
104 
 
induced peripheral neurotoxicity using the Total Neuropathy Scale. Neurology 61: 
1297-1300, 2003. 
19. Cerutti C, Barres C, and Paultre C. Baroreflex modulation of blood 
pressure and heart rate variabilities in rats: assessment by spectral analysis. Am 
J Physiol 266: H1993-2000, 1994. 
20. Chang AT, Boots RJ, Brown MG, Paratz JD, and Hodges PW. Ventilatory 
changes following head-up tilt and standing in healthy subjects. Eur J Appl 
Physiol 95: 409-417, 2005. 
21. Charkoudian N. Skin blood flow in adult human thermoregulation: how it 
works, when it does not, and why. Mayo Clin Proc 78: 603-612, 2003. 
22. Claus D, Meudt O, Rozeik C, Engelmann-Kempe K, Huppert PE, and 
Wietholtz H. Prospective investigation of autonomic cardiac neuropathy in 
diabetes mellitus. Clin Auton Res 12: 373-378, 2002. 
23. Colantuoni A, Bertuglia S, and Intaglietta M. Microvascular vasomotion: 
origin of laser Doppler flux motion. International journal of microcirculation, 
clinical and experimental / sponsored by the European Society for 
Microcirculation 14: 151-158, 1994. 
24. Combe H, Bauduceau B, Chanudet X, Chau NP, Rabasa R, Meyer L, 
Mayaudon H, Larroque P, and Gautier D. [Cardiovascular autonomic neuropathy 
and blood pressure variability in insulin-dependent diabetes]. Arch Mal Coeur 
Vaiss 86: 1149-1152, 1993. 
25. Cooke WH, Rickards CA, Ryan KL, Kuusela TA, and Convertino VA. 
Muscle sympathetic nerve activity during intense lower body negative pressure to 
presyncope in humans. J Physiol 587: 4987-4999, 2009. 
26. Crick SJ, Anderson RH, Ho SY, and Sheppard MN. Localisation and 
quantitation of autonomic innervation in the porcine heart II: endocardium, 
myocardium and epicardium. Journal of anatomy 195 ( Pt 3): 359-373, 1999. 
27. de Sousa MR, Huikuri HV, Lombardi F, Perez AA, Gomes ME, Barros MV, 
Barros VC, Rocha MO, and Ribeiro AL. Abnormalities in fractal heart rate 
dynamics in Chagas disease. Ann Noninvasive Electrocardiol 11: 145-153, 2006. 
105 
 
28. Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, Maggio P, 
Palazzo P, Sgreccia F, Peraldo C, Farina F, Frajese G, and Frontoni S. Impact of 
Glycemic and Blood Pressure Variability on Surrogate Measures of 
Cardiovascular Outcomes in Type 2 Diabetic Patients. Diabetes Care 2011. 
29. Di Rienzo M, Castiglioni P, Parati G, Mancia G, and Pedotti A. Effects of 
sino-aortic denervation on spectral characteristics of blood pressure and pulse 
interval variability: a wide-band approach. Medical and Biological Engineering 
and Computing 34: 133-141, 1996. 
30. Di Rienzo M, Parati G, Castiglioni P, Omboni S, Ferrari AU, Ramirez AJ, 
Pedotti A, and Mancia G. Role of sinoaortic afferents in modulating BP and 
pulse-interval spectral characteristics in unanesthetized cats. American Journal 
of Physiology - Heart and Circulatory Physiology 261: H1811-H1818, 1991. 
31. Di Rienzo M, Parati G, Castiglioni P, Tordi R, Mancia G, and Pedotti A. 
Baroreflex effectiveness index: an additional measure of baroreflex control of 
heart rate in daily life. Am J Physiol Regul Integr Comp Physiol 280: R744-751, 
2001. 
32. Ducher M, Cerutti C, Gustin MP, Abou-Amara S, Thivolet C, Laville M, 
Paultre CZ, and Fauvel JP. Noninvasive exploration of cardiac autonomic 
neuropathy. Four reliable methods for diabetes? Diabetes Care 22: 388-393, 
1999. 
33. Durrer D, van Dam RT, Freud GE, Janse MJ, Meijler FL, and Arzbaecher 
RC. Total excitation of the isolated human heart. Circulation 41: 899-912, 1970. 
34. Eke A, Herman P, Kocsis L, and Kozak LR. Fractal characterization of 
complexity in temporal physiological signals. Physiol Meas 23: R1-38, 2002. 
35. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, 
Cohen JA, Fisher MA, Howard JF, Kinsella LJ, Latov N, Lewis RA, Low PA, and 
Sumner AJ. Distal symmetric polyneuropathy: a definition for clinical research: 
report of the American Academy of Neurology, the American Association of 
Electrodiagnostic Medicine, and the American Academy of Physical Medicine 
and Rehabilitation. Neurology 64: 199-207, 2005. 
106 
 
36. Evans JM, Leonelli FM, Ziegler MG, McIntosh CM, Patwardhan AR, Ertl 
AC, Kim CS, and Knapp CF. Epinephrine, vasodilation and hemoconcentration in 
syncopal, healthy men and women. Auton Neurosci 93: 79-90, 2001. 
37. Evans JM, Ziegler MG, Patwardhan AR, Ott JB, Kim CS, Leonelli FM, and 
Knapp CF. Gender differences in autonomic cardiovascular regulation: spectral, 
hormonal, and hemodynamic indexes. J Appl Physiol 91: 2611-2618, 2001. 
38. Ewing D, Boland O, Neilson J, Cho C, and Clarke B. Autonomic 
neuropathy, QT interval lengthening, and unexpected deaths in male diabetic 
patients. Diabetologia 34: 182-185, 1991. 
39. Ewing DJ, and Clarke BF. Diagnosis and management of diabetic 
autonomic neuropathy. Br Med J (Clin Res Ed) 285: 916-918, 1982. 
40. Fallouh HB, Bardswell SC, McLatchie LM, Shattock MJ, Chambers DJ, 
and Kentish JC. Esmolol cardioplegia: the cellular mechanism of diastolic arrest. 
Cardiovascular Research 87: 552-560, 2010. 
41. Farina D, and Dossel O. Model-based approach to the localization of 
infarction. In: Computers in Cardiology, 2007IEEE, 2007, p. 173-176. 
42. Foo JY, and Lim CS. Dual-channel photoplethysmography to monitor local 
changes in vascular stiffness. J Clin Monit Comput 20: 221-227, 2006. 
43. Frattola A, Parati G, Castiglioni P, Paleari F, Ulian L, Rovaris G, Mauri G, 
Di Rienzo M, and Mancia G. Lacidipine and Blood Pressure Variability in Diabetic 
Hypertensive Patients. Hypertension 36: 622-628, 2000. 
44. Frattola A, Parati G, Gamba P, Paleari F, Mauri G, Di Rienzo M, 
Castiglioni P, and Mancia G. Time and frequency domain estimates of 
spontaneous baroreflex sensitivity provide early detection of autonomic 
dysfunction in diabetes mellitus. Diabetologia 40: 1470-1475, 1997. 
45. Freeman R, Saul JP, Roberts MS, Berger RD, Broadbridge C, and Cohen 
RJ. Spectral analysis of heart rate in diabetic autonomic neuropathy. A 
comparison with standard tests of autonomic function. Arch Neurol 48: 185-190, 
1991. 
107 
 
46. Fu Q, Shook RP, Okazaki K, Hastings JL, Shibata S, Conner CL, Palmer 
MD, and Levine BD. Vasomotor sympathetic neural control is maintained during 
sustained upright posture in humans. J Physiol 577: 679-687, 2006. 
47. Furlan R, Porta A, Costa F, Tank J, Baker L, Schiavi R, Robertson D, 
Malliani A, and Mosqueda-Garcia R. Oscillatory patterns in sympathetic neural 
discharge and cardiovascular variables during orthostatic stimulus. Circulation 
101: 886-892, 2000. 
48. Ghosh S, Rhee EK, Avari JN, Woodard PK, and Rudy Y. Cardiac memory 
in patients with Wolff-Parkinson-White syndrome: noninvasive imaging of 
activation and repolarization before and after catheter ablation. Circulation 118: 
907-915, 2008. 
49. Giordano A, Calcagni ML, Verrillo A, Pellegrinotti M, Frontoni S, Spallone 
V, and Gambardella S. Assessment of sympathetic innervation of the heart in 
diabetes mellitus using 123I-MIBG. Diabetes Nutr Metab 13: 350-355, 2000. 
50. Goldberger AL, and West BJ. Fractals in physiology and medicine. Yale J 
Biol Med 60: 421-435, 1987. 
51. Gonin JM, Kadrofske MM, Schmaltz S, Bastyr EJ, and Vinik AI. Corrected 
Q-T Interval Prolongation as Diagnostic Tool for Assessment of Cardiac 
Autonomic Neuropathy in Diabetes Mellitus. Diabetes Care 13: 68-71, 1990. 
52. Gregoire J, Tuck S, Yamamoto Y, and Hughson RL. Heart rate variability 
at rest and exercise: influence of age, gender, and physical training. Can J Appl 
Physiol 21: 455-470, 1996. 
53. Gulrajani RM. The forward and inverse problems of electrocardiography. 
IEEE engineering in medicine and biology magazine : the quarterly magazine of 
the Engineering in Medicine & Biology Society 17: 84-101, 122, 1998. 
54. Hage FG, and Iskandrian AE. Cardiac autonomic denervation in diabetes 
mellitus. Circulation Cardiovascular imaging 4: 79-81, 2011. 
55. Hattori N, Rihl J, Bengel FM, Nekolla SG, Standl E, Schwaiger M, and 
Schnell O. Cardiac autonomic dysinnervation and myocardial blood flow in long-
term Type 1 diabetic patients. Diabetic Medicine 20: 375-381, 2003. 
108 
 
56. Hattori N, Tamaki N, Hayashi T, Masuda I, Kudoh T, Tateno M, Tadamura 
E, Yonekura Y, Nakao K, and Konishi J. Regional abnormality of iodine-123-
MIBG in diabetic hearts. Journal of nuclear medicine : official publication, Society 
of Nuclear Medicine 37: 1985-1990, 1996. 
57. Hertzman AB, Randall WC, Peiss CN, and Seckendorf R. Regional rates 
of evaporation from the skin at various environmental temperatures. J Appl 
Physiol 5: 153-161, 1952. 
58. Hodges GJ, and Johnson JM. Adrenergic control of the human cutaneous 
circulation. Applied Physiology, Nutrition, and Metabolism 34: 829-839, 2009. 
59. Holowatz LA. Sex differences in the control of acral skin blood flow in 
humans: differential regulation of cyclooxygenase in alpha-adrenergic signalling. 
J Physiol 589: 5017, 2011. 
60. Howorka K, Pumprla J, and Schabmann A. Optimal parameters of short-
term heart rate spectrogram for routine evaluation of diabetic cardiovascular 
autonomic neuropathy. J Auton Nerv Syst 69: 164-172, 1998. 
61. Ishaque MR, Ahmed SA, and Abid I. Comparison of the ambulatory blood 
pressure variability in diabetic hypertensive and non diabetic hypertensive 
patients. Ann Pak Inst Med Sci 5: 174-177, 2009. 
62. Jepsen H, and Gaehtgens P. Postural vascular response vs. sympathetic 
vasoconstriction in human skin during orthostasis. American Journal of 
Physiology - Heart and Circulatory Physiology 269: H53-H61, 1995. 
63. Ji S, and Travin M. Radionuclide imaging of cardiac autonomic innervation. 
Journal of Nuclear Cardiology 17: 655-666, 2010. 
64. Johansson M, Gao SA, Friberg P, Annerstedt M, Bergstrom G, Carlstrom 
J, Ivarsson T, Jensen G, Ljungman S, Mathillas O, Nielsen FD, and Strombom U. 
Reduced baroreflex effectiveness index in hypertensive patients with chronic 
renal failure. Am J Hypertens 18: 995-1000; discussion 1016, 2005. 
65. Johnson JM, Pergola PE, Liao FK, Kellogg DL, and Crandall CG. Skin of 
the dorsal aspect of human hands and fingers possesses an active vasodilator 
system. Journal of Applied Physiology 78: 948-954, 1995. 
109 
 
66. Kamath GS, and Mittal S. The Role of Antiarrhythmic Drug Therapy for the 
Prevention of Sudden Cardiac Death. Progress in Cardiovascular Diseases 50: 
439-448, 2008. 
67. Kardos A, Rudas L, Simon J, Gingl Z, and Csanady M. Effect of postural 
changes on arterial baroreflex sensitivity assessed by the spontaneous sequence 
method and Valsalva manoeuvre in healthy subjects. Clin Auton Res 7: 143-148, 
1997. 
68. Keller DU, Seemann G, Weiss DL, Farina D, Zehelein J, and Dossel O. 
Computer based modeling of the congenital long-QT 2 syndrome in the Visible 
Man torso: from genes to ECG. Conf Proc IEEE Eng Med Biol Soc 2007: 1410-
1413, 2007. 
69. Kempler P, Varadi A, Szalay F, and Tamas G. Autonomic neuropathy and 
corrected QT interval prolongation. There is a relationship. Diabetes Care 17: 
454-456, 1994. 
70. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, Ota 
M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, and Imai Y. Prognostic 
Significance of Blood Pressure and Heart Rate Variabilities : The Ohasama 
Study. Hypertension 36: 901-906, 2000. 
71. Kilpatrick ES, Rigby AS, and Atkin SL. The Role of Blood Pressure 
Variability in the Development of Nephropathy in Type 1 Diabetes. Diabetes Care 
33: 2442-2447, 2010. 
72. Krause M, Rudiger H, Bald M, Nake A, and Paditz E. Autonomic blood 
pressure control in children and adolescents with type 1 diabetes mellitus. 
Pediatr Diabetes 10: 255-263, 2009. 
73. Krishnamurthy S, Wang X, Bhakta D, Bruce E, Evans J, Justice T, and 
Patwardhan A. Dynamic cardiorespiratory interaction during head-up tilt-
mediated presyncope. Am J Physiol Heart Circ Physiol 287: H2510-2517, 2004. 
74. Langen KJ, Ziegler D, Weise F, Piolot R, Boy C, Hubinger A, Gries FA, 
and Muller-Gartner HW. Evaluation of QT interval length, QT dispersion and 
myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients 
with and without autonomic neuropathy. Clin Sci (Lond) 93: 325-333, 1997. 
110 
 
75. Langer A, Freeman MR, Josse RG, and Armstrong PW. 
Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac 
sympathetic denervation and its relation to autonomic dysfunction and silent 
myocardial ischemia. Journal of the American College of Cardiology 25: 610-618, 
1995. 
76. Langley P, Smith FE, King ST, Zheng D, Haigh AJ, and Murray A. Fully 
automated computer measurement of QT interval from the 12-lead 
electrocardiogram. In: Computers in Cardiology, 20062006, p. 345-348. 
77. Leahy MJ, de Mul FF, Nilsson GE, and Maniewski R. Principles and 
practice of the laser-Doppler perfusion technique. Technol Health Care 7: 143-
162, 1999. 
78. Leonelli FM, Wang K, Evans JM, Patwardhan AR, Ziegler MG, Natale A, 
Kim CS, Rajikovich K, and Knapp CF. False positive head-up tilt: hemodynamic 
and neurohumoral profile. J Am Coll Cardiol 35: 188-193, 2000. 
79. Levick JR. An introduction to cardiovascular physiology. London, New 
York: Arnold; Distributed in the United States of America by Oxford University 
Press, 2003, p. 265 p. 
80. Liao D, Barnes RW, Chambless LE, Simpson RJ, Jr., Sorlie P, and Heiss 
G. Age, race, and sex differences in autonomic cardiac function measured by 
spectral analysis of heart rate variability--the ARIC study. Atherosclerosis Risk in 
Communities. Am J Cardiol 76: 906-912, 1995. 
81. Linnemann B, and Janka HU. Prolonged QTc interval and elevated heart 
rate identify the type 2 diabetic patient at high risk for cardiovascular death. The 
Bremen Diabetes Study. Exp Clin Endocrinol Diabetes 111: 215-222, 2003. 
82. Malik M, and Batchvarov VN. Measurement, interpretation and clinical 
potential of QT dispersion. J Am Coll Cardiol 36: 1749-1766, 2000. 
83. Matel D, Chiochina AD, and Stratone A. [Utility of QTc interval for the 
diagnosis of cardiac autonomic neuropathy in type 2 diabetes mellitus]. Rev Med 
Chir Soc Med Nat Iasi 114: 282-286, 2010. 
84. Meendering JR, Torgrimson BN, Houghton BL, Halliwill JR, and Minson 
CT. Menstrual cycle and sex affect hemodynamic responses to combined 
111 
 
orthostatic and heat stress. Am J Physiol Heart Circ Physiol 289: H631-642, 
2005. 
85. Meyer MF, Rose CJ, Hülsmann JO, Schatz H, and Pfohl M. Impaired 0.1-
Hz vasomotion assessed by laser Doppler anemometry as an early index of 
peripheral sympathetic neuropathy in diabetes. Microvascular Research 65: 88-
95, 2003. 
86. Miller WT, and Geselowitz DB. Simulation studies of the 
electrocardiogram. I. The normal heart. Circ Res 43: 301-315, 1978. 
87. Mokhtar RH, Ayob A, and Mohd Noor N. Blood Pressure Variability in 
Patients with Diabetes Mellitus. Asian Cardiovasc Thorac Ann 18: 344-348, 2010. 
88. Morillo CA, Eckberg DL, Ellenbogen KA, Beightol LA, Hoag JB, 
Tahvanainen KUO, Kuusela TA, and Diedrich AM. Vagal and Sympathetic 
Mechanisms in Patients With Orthostatic Vasovagal Syncope. Circulation 96: 
2509-2513, 1997. 
89. Morita ST, Zipes DP, Morita H, and Wu J. Analysis of action potentials in 
the canine ventricular septum: no phenotypic expression of M cells. Cardiovasc 
Res 74: 96-103, 2007. 
90. Naas AA, Davidson NC, Thompson C, Cummings F, Ogston SA, Jung RT, 
Newton RW, and Struthers AD. QT and QTc dispersion are accurate predictors 
of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort 
study. BMJ 316: 745-746, 1998. 
91. Nagamachi S, Hoshi H, Ohnishi T, Jinnouchi S, Futami S, Watanabe K, 
Nakatsuru K, Toshimori T, and Matsukura S. [123I-MIBG myocardial scintigraphy 
in diabetic patients: association with autonomic neuropathy]. Kaku Igaku 31: 
1059-1069, 1994. 
92. Nagamachi S, Jinnouchi S, Kurose T, Ohnishi T, Flores LG, 2nd, 
Nakahara H, Futami S, Tamura S, and Matsukura S. 123I-MIBG myocardial 
scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac 
autonomic function. Ann Nucl Med 12: 323-331, 1998. 
93. Nagamachi S, Jinnouchi S, Nakahara H, Flores LG, 2nd, Ohnishi T, Hoshi 
H, Futami S, Watanabe K, Nakatsuru K, Toshimori T, and Matsukura S. 123I-
112 
 
MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic 
neuropathy. Nucl Med Commun 17: 621-632, 1996. 
94. Norman AE. 12 Lead ECG Interpretation: A Self-teaching Manual. 
McGraw-Hill, 1992. 
95. O'Leary DD, Kimmerly DS, Cechetto AD, and Shoemaker JK. Differential 
effect of head-up tilt on cardiovagal and sympathetic baroreflex sensitivity in 
humans. Exp Physiol 88: 769-774, 2003. 
96. O'Leary DD, Lin DC, and Hughson RL. Determination of baroreflex gain 
using auto-regressive moving-average analysis during spontaneous breathing. 
Clin Physiol 19: 369-377, 1999. 
97. Omboni S, Parati G, Di Rienzo M, Wieling W, and Mancia G. Blood 
pressure and heart rate variability in autonomic disorders: a critical review. Clin 
Auton Res 6: 171-182, 1996. 
98. Ong JJ, Sarma JS, Venkataraman K, Levin SR, and Singh BN. Circadian 
rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: 
implications for the mechanism of sudden death. Am Heart J 125: 744-752, 1993. 
99. Pagani M, Malfatto G, Pierini S, Casati R, Masu AM, Poli M, Guzzetti S, 
Lombardi F, Cerutti S, and Malliani A. Spectral analysis of heart rate variability in 
the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst 23: 143-
153, 1988. 
100. Pappachan JM, Sebastian J, Bino BC, Jayaprakash K, Vijayakumar K, 
Sujathan P, and Adinegara LA. Cardiac autonomic neuropathy in diabetes 
mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG 
for its diagnosis. Postgrad Med J 84: 205-210, 2008. 
101. Parati G, Saul JP, Di Rienzo M, and Mancia G. Spectral analysis of blood 
pressure and heart rate variability in evaluating cardiovascular regulation. A 
critical appraisal. Hypertension 25: 1276-1286, 1995. 
102. Patwardhan AR, Vallurupalli S, Evans JM, Bruce EN, and Knapp CF. 
Override of spontaneous respiratory pattern generator reduces cardiovascular 
parasympathetic influence. J Appl Physiol 79: 1048-1054, 1995. 
113 
 
103. Peralta AO, John RM, Gaasch WH, Taggart PI, Martin DT, and Venditti FJ. 
The class III antiarrhythmic effect of sotalol exerts a reverse use-dependent 
positive inotropic effect in the intact canine heart. Journal of the American 
College of Cardiology 36: 1404-1410, 2000. 
104. Philip J. Weston MAJ, Ronnie B. Panerai, Paul G. McNally, John F. Potter 
and Herbert Thurston. Evidence of defective cardiovascular regulation in insulin-
dependent diabetic patients without clinical autonomic dysfunction. Diabetes 
Research and Clinical Practice 42: 141-148, 1998. 
105. Plonsey R, and Fleming DG. Bioelectric phenomena. New York,: McGraw-
Hill, 1969, p. xiv, 380 p. 
106. Rana BS, Lim PO, Naas AA, Ogston SA, Newton RW, Jung RT, Morris 
AD, and Struthers AD. QT interval abnormalities are often present at diagnosis in 
diabetes and are better predictors of cardiac death than ankle brachial pressure 
index and autonomic function tests. Heart 91: 44-50, 2005. 
107. Ribeiro AL, Lombardi F, Sousa MR, Lins Barros MV, Porta A, Costa Val 
Barros V, Gomes ME, Santana Machado F, and Otavio Costa Rocha M. Power-
law behavior of heart rate variability in Chagas' disease. Am J Cardiol 89: 414-
418, 2002. 
108. Rossing P, Breum L, Major-Pedersen A, Sato A, Winding H, Pietersen A, 
Kastrup J, and Parving HH. Prolonged QTc interval predicts mortality in patients 
with Type 1 diabetes mellitus. Diabet Med 18: 199-205, 2001. 
109. Rowell LB. Human cardiovascular control. New York: Oxford University 
Press, 1993, p. xv, 500 p. 
110. Ruiz J, Monbaron D, Parati G, Perret S, Haesler E, Danzeisen C, and 
Hayoz D. Diabetic Neuropathy Is a More Important Determinant of Baroreflex 
Sensitivity Than Carotid Elasticity in Type 2 Diabetes. Hypertension 46: 162-167, 
2005. 
111. Sagawa S, Shiraki K, Miki K, and Tajima F. Cardiovascular responses to 
upright tilt at a simulated altitude of 3,700 m in men. Aviat Space Environ Med 64: 
219-223, 1993. 
114 
 
112. Schnell O, Hammer K, Muhr-Becker D, Ziegler A, Weiss M, Tatsch K, and 
Standl E. Cardiac sympathetic dysinnervation in Type 2 diabetes mellitus with 
and without ECG-based cardiac autonomic neuropathy. J Diabetes 
Complications 16: 220-227, 2002. 
113. Schnell O, Kirsch CM, Stemplinger J, Haslbeck M, and Standl E. 
Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM 
patients with and without ECG-based autonomic neuropathy. Diabetologia 38: 
1345-1352, 1995. 
114. Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, and Standl E. 
Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed 
IDDM patients. Diabetes 45: 801-805, 1996. 
115. Scholte AJ, Schuijf JD, Delgado V, Kok JA, Bus MT, Maan AC, Stokkel 
MP, Kharagitsingh AV, Dibbets-Schneider P, van der Wall EE, and Bax JJ. 
Cardiac autonomic neuropathy in patients with diabetes and no symptoms of 
coronary artery disease: comparison of 123I-metaiodobenzylguanidine 
myocardial scintigraphy and heart rate variability. Eur J Nucl Med Mol Imaging 37: 
1698-1705, 2010. 
116. Scott LA, and Kench PL. Cardiac autonomic neuropathy in the diabetic 
patient: does 123I-MIBG imaging have a role to play in early diagnosis? Journal 
of nuclear medicine technology 32: 66-71, 2004. 
117. Shibasaki M, Davis SL, Cui J, Low DA, Keller DM, Durand S, and Crandall 
CG. Neurally mediated vasoconstriction is capable of decreasing skin blood flow 
during orthostasis in the heat-stressed human. J Physiol 575: 953-959, 2006. 
118. Sicouri S, Fish J, and Antzelevitch C. Distribution of M cells in the canine 
ventricle. J Cardiovasc Electrophysiol 5: 824-837, 1994. 
119. Stansberry KB, Shapiro SA, Hill MA, McNitt PM, Meyer MD, and Vinik AI. 
Impaired Peripheral Vasomotion in Diabetes. Diabetes Care 19: 715-721, 1996. 
120. Stauss HM, Anderson EA, Haynes WG, and Kregel KC. Frequency 
response characteristics of sympathetically mediated vasomotor waves in 
humans. American Journal of Physiology - Heart and Circulatory Physiology 274: 
H1277-H1283, 1998. 
115 
 
121. Stemper B, Bernardi L, Axelrod FB, Welsch G, Passino C, and Hilz MJ. 
Sympathetic and parasympathetic baroreflex dysfunction in familial 
dysautonomia. Neurology 63: 1427-1431, 2004. 
122. Stevens MJ. New imaging techniques for cardiovascular autonomic 
neuropathy: a window on the heart. Diabetes Technol Ther 3: 9-22, 2001. 
123. Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, 
Wieland DM, Pfeifer MA, and Schwaiger M. Cardiac sympathetic dysinnervation 
in diabetes: implications for enhanced cardiovascular risk. Circulation 98: 961-
968, 1998. 
124. Sundkvist G. Autonomic nervous function in asymptomatic diabetic 
patients with signs of peripheral neuropathy. Diabetes Care 4: 529-534, 1981. 
125. Tentolouris N, Katsilambros N, Papazachos G, Papadogiannis D, Linos A, 
Stamboulis E, and Papageorgiou K. Corrected QT interval in relation to the 
severity of diabetic autonomic neuropathy. Eur J Clin Invest 27: 1049-1054, 1997. 
126. Veglio M, Borra M, Stevens LK, Fuller JH, and Perin PC. The relation 
between QTc interval prolongation and diabetic complications. The EURODIAB 
IDDM Complication Study Group. Diabetologia 42: 68-75, 1999. 
127. Veglio M, Sivieri R, Chinaglia A, Scaglione L, and Cavallo-Perin P. QT 
interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort 
prospective study. Neuropathy Study Group of the Italian Society of the Study of 
Diabetes, Piemonte Affiliate. Diabetes Care 23: 1381-1383, 2000. 
128. Vinik AI, and Erbas T. Cardiovascular autonomic neuropathy: diagnosis 
and management. Curr Diab Rep 6: 424-430, 2006. 
129. Vinik AI, and Erbas T. Recognizing and treating diabetic autonomic 
neuropathy. Cleve Clin J Med 68: 928-930, 932, 934-944, 2001. 
130. Vinik AI, Maser RE, Mitchell BD, and Freeman R. Diabetic autonomic 
neuropathy. Diabetes Care 26: 1553-1579, 2003. 
131. Vinik AI, and Mehrabyan A. Diagnosis and management of diabetic 
autonomic neuropathy. Compr Ther 29: 130-145, 2003. 
116 
 
132. Wagner CD, Mrowka R, Nafz B, and Persson PB. Complexity and "chaos" 
in blood pressure after baroreceptor denervation of conscious dogs. Am J 
Physiol 269: H1760-1766, 1995. 
133. Wagner CD, and Persson PB. Two ranges in blood pressure power 
spectrum with different 1/f characteristics. American Journal of Physiology - 
Heart and Circulatory Physiology 267: H449-H454, 1994. 
134. Wallin BG, Sundlof G, and Delius W. The effect of carotid sinus nerve 
stimulation on muscle and skin nerve sympathetic activity in man. Pflugers Arch 
358: 101-110, 1975. 
135. White WB. Diurnal blood pressure and blood pressure variability in 
diabetic normotensive and hypertensive subjects. Journal of Hypertension 10: 
S43, 1992. 
136. Xie X, Visweswaran R, Guzman PA, Smith RM, Osborn JW, and 
Tolkacheva EG. The effect of cardiac sympathetic denervation through bilateral 
stellate ganglionectomy on electrical properties of the heart. American Journal of 
Physiology - Heart and Circulatory Physiology 301: H192-H199, 2011. 
137. Yan GX, and Antzelevitch C. Cellular basis for the normal T wave and the 
electrocardiographic manifestations of the long-QT syndrome. Circulation 98: 
1928-1936, 1998. 
138. Yan GX, Shimizu W, and Antzelevitch C. Characteristics and distribution 
of M cells in arterially perfused canine left ventricular wedge preparations. 
Circulation 98: 1921-1927, 1998. 
139. Yanowitz F, Preston JB, and Abildskov JA. Functional distribution of right 
and left stellate innervation to the ventricles. Production of neurogenic 
electrocardiographic changes by unilateral alteration of sympathetic tone. Circ 
Res 18: 416-428, 1966. 
140. Yoshioka K, Gao D-W, Chin M, Stillson C, Penades E, Lesh M, O’Connell 
W, and Dae M. Heterogeneous Sympathetic Innervation Influences Local 
Myocardial Repolarization in Normally Perfused Rabbit Hearts. Circulation 101: 
1060-1066, 2000. 
117 
 
141. Zhang Q, Zhang X, Chang B, Qiu B, Zhang Y, Li J, and Zeng Z. Blood 
pressure variability correlates with target-organ damage in elderly patients with 
hypertension]. Sichuan da xue xue bao Yi xue ban= Journal of Sichuan 
University Medical science edition 42: 252, 2011. 
142. Ziegler D. Diabetic cardiovascular autonomic neuropathy. Diabetic 
Neuropathy Edit by Aventis Pharma, Inc 140-169, 2001. 
143. Ziegler D, Gries FA, Spuler M, and Lessmann F. The epidemiology of 
diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter 
Study Group. J Diabetes Complications 6: 49-57, 1992. 
144. Ziegler D, Laude D, Akila F, and Elghozi JL. Time- and frequency-domain 
estimation of early diabetic cardiovascular autonomic neuropathy. Clin Auton Res 
11: 369-376, 2001. 
145. Zipes DP, and Jalife J. Cardiac electrophysiology : from cell to bedside. 
Philadelphia: Saunders, 2004, p. xvi, 1144 p. 
 
 
  
118 
 
VITA 
Student Name: Siqi Wang 
Educational Institutions 
September 2004 - July 2008  Sun Yat-sen University, China, Bachelor of 
Science in Biomedical Engineering 
Professional Positions 
August 2008 - December 2012  Research Assistant, Center for Biomedical 
Engineering, Wenner-Gren Research Laboratory, University of Kentucky 
Peer Reviewed Publications 
1. Siqi Wang, David C. Randall, Charles F. Knapp, Abhijit R. Patwardhan, 
Kevin R. Nelson, Dennis G. Karounos, Joyce M. Evans. Blood pressure 
regulation in diabetic patients with and without peripheral neuropathy.  Am 
J Physiol Regul Integr Comp Physiol 302: R541-550, 2012. 
Abstract 
1. Siqi Wang, André Diedrich, Vladimir Kostas, Rachel Moore, Mat Stasuk, 
Charles Knapp, Joyce Evans. Postural Changes in Human Stroke 
Volume: Bio-Impedance vs. Ultrasound Estimates. Gill Heart Institute, 
15th Annual Cardiovascular Research Day, October, 2012 
 
2. Siqi Wang, André Diedrich, Vladimir Kostas, Rachel Moore, Mat Stasuk, 
Charles Knapp, Joyce Evans. Estimation of Postural Changes in Human 
Stroke Volume from Bio-Impedance. BMES Annual Meeting, Atlanta, GA, 
October, 24-27, 2012  
 
3. Qingguang Zhang, Joyce M Evans, Vladimir Kostas, Siqi Wang, Charles 
F Knapp, Cardiovascular Responses of Men and Women to Orthostasis in 
Simulated Lunar and Martian Gravities. BMES Annual Meeting, Atlanta, 
GA, October, 24-27, 2012 
 
4. Siqi Wang, David Randall, Charles Knapp, Kevin Nelson, Abhijit 
Patwardhan, Joyce Evans. Noninvasive assessment of cardiovascular 
autonomic neuropathy. Gill Heart Institute, 14th Annual Cardiovascular 
Research Day, October, 2011  
 
5. JM Evans, S Wang, V Kostas, Q Zhang, SC Elayi, MB Stenger, CF 
Knapp. Orthostatic Fluid Shifts in Earth and Simulated Moon and Mars 
Environments. AGSB/ISGP annual meeting, San Jose, CA, November 3-
7, 2011.  
119 
 
 
6. VI Kostas, MB Stenger, CF Knapp, RS. Shapiro, EE. Salmon, S 
Wang, A Diedrich, and JM Evans. Cardiovascular responses to 
standing in earth and simulated moon and mars gravity environments. 
American College of Sports Medicine, Denver, CO, June, 2011.    
 
7. VI Kostas, MB Stenger, CF Knapp, RS. Shapiro, EE. Salmon, S Wang, A 
Diedrich, and JM Evans. Cardiovascular models of simulated moon and 
mars gravities: Head up tilt vs lower body unweighting. Humans in Space 
Conference, Houston Texas, April, 2011  
 
8. S Wang, DC Randall, CF Knapp, KR Nelson, AR Patwardhan and JM Evans.  
Noninvasive assessment of cardiovascular autonomic neuropathy. FASEB 
Jnl 25, 2011. 
 
9. Siqi Wang, David Randall, Charles Knapp, Kevin Nelson, Abhijit 
Patwardhan, Joyce Evans. Autonomic regulation in patients with diabetic 
neuropathy. Gill Heart Institute, 13th Annual Cardiovascular Research Day, 
October, 2010 
 
10. S Wang, DC Randall, CF Knapp, KR Nelson, AR Patwardhan, PJ Kilfoil, 
and JM Evans. Autonomic regulation in patients with diabetic neuropathy. 
FASEB Jnl  24, 2010. 
 
11. JM Evans, PJ Kilfoil, S Wang, L Mohney and CF Knapp. Cardiovascular 
responses to standing and walking in earth and simulated moon and mars 
gravities. FASEB Jnl  24, 2010. 
 
12. Siqi Wang, David Randall, Charles Knapp, Abhijit Patwardhan, Peter 
Kilfoil, Joyce Evans. Dysfunction of autonomic regulation of short term 
blood pressure in diabetes. Gill Heart Institute, 12th Annual Cardiovascular 
Research Day, October, 2009 
Scholastic and Professional Honors 
2012 University of Kentucky, Graduate School, Max Steckler Fellowship 
2012   University of Kentucky, Office of International Affairs, International 
Student Tuition Scholarship  
2012   University of Kentucky, College of Engineering, Halcomb Fellowhsip 
